<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T05:19:37Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:4794224" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:4794224</identifier>
        <datestamp>2016-03-23</datestamp>
        <setSpec>plosone</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">PLoS One</journal-id>
              <journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id>
              <journal-id journal-id-type="publisher-id">plos</journal-id>
              <journal-id journal-id-type="pmc">plosone</journal-id>
              <journal-title-group>
                <journal-title>PLoS ONE</journal-title>
              </journal-title-group>
              <issn pub-type="epub">1932-6203</issn>
              <publisher>
                <publisher-name>Public Library of Science</publisher-name>
                <publisher-loc>San Francisco, CA USA</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC4794224</article-id>
              <article-id pub-id-type="pmcid">PMC4794224</article-id>
              <article-id pub-id-type="pmc-uid">4794224</article-id>
              <article-id pub-id-type="pmid">26983081</article-id>
              <article-id pub-id-type="pmid">26983081</article-id>
              <article-id pub-id-type="doi">10.1371/journal.pone.0151364</article-id>
              <article-id pub-id-type="publisher-id">PONE-D-15-49743</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Research Article</subject>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Microbiology</subject>
                    <subj-group>
                      <subject>Medical Microbiology</subject>
                      <subj-group>
                        <subject>Microbial Pathogens</subject>
                        <subj-group>
                          <subject>Viral Pathogens</subject>
                          <subj-group>
                            <subject>Immunodeficiency Viruses</subject>
                            <subj-group>
                              <subject>HIV</subject>
                            </subj-group>
                          </subj-group>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Pathology and Laboratory Medicine</subject>
                    <subj-group>
                      <subject>Pathogens</subject>
                      <subj-group>
                        <subject>Microbial Pathogens</subject>
                        <subj-group>
                          <subject>Viral Pathogens</subject>
                          <subj-group>
                            <subject>Immunodeficiency Viruses</subject>
                            <subj-group>
                              <subject>HIV</subject>
                            </subj-group>
                          </subj-group>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Organisms</subject>
                    <subj-group>
                      <subject>Viruses</subject>
                      <subj-group>
                        <subject>Viral Pathogens</subject>
                        <subj-group>
                          <subject>Immunodeficiency Viruses</subject>
                          <subj-group>
                            <subject>HIV</subject>
                          </subj-group>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Organisms</subject>
                    <subj-group>
                      <subject>Viruses</subject>
                      <subj-group>
                        <subject>Immunodeficiency Viruses</subject>
                        <subj-group>
                          <subject>HIV</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and life sciences</subject>
                  <subj-group>
                    <subject>Organisms</subject>
                    <subj-group>
                      <subject>Viruses</subject>
                      <subj-group>
                        <subject>RNA viruses</subject>
                        <subj-group>
                          <subject>Retroviruses</subject>
                          <subj-group>
                            <subject>Lentivirus</subject>
                            <subj-group>
                              <subject>HIV</subject>
                            </subj-group>
                          </subj-group>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Microbiology</subject>
                    <subj-group>
                      <subject>Medical Microbiology</subject>
                      <subj-group>
                        <subject>Microbial Pathogens</subject>
                        <subj-group>
                          <subject>Viral Pathogens</subject>
                          <subj-group>
                            <subject>Retroviruses</subject>
                            <subj-group>
                              <subject>Lentivirus</subject>
                              <subj-group>
                                <subject>HIV</subject>
                              </subj-group>
                            </subj-group>
                          </subj-group>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Pathology and Laboratory Medicine</subject>
                    <subj-group>
                      <subject>Pathogens</subject>
                      <subj-group>
                        <subject>Microbial Pathogens</subject>
                        <subj-group>
                          <subject>Viral Pathogens</subject>
                          <subj-group>
                            <subject>Retroviruses</subject>
                            <subj-group>
                              <subject>Lentivirus</subject>
                              <subj-group>
                                <subject>HIV</subject>
                              </subj-group>
                            </subj-group>
                          </subj-group>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Organisms</subject>
                    <subj-group>
                      <subject>Viruses</subject>
                      <subj-group>
                        <subject>Viral Pathogens</subject>
                        <subj-group>
                          <subject>Retroviruses</subject>
                          <subj-group>
                            <subject>Lentivirus</subject>
                            <subj-group>
                              <subject>HIV</subject>
                            </subj-group>
                          </subj-group>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>People and Places</subject>
                  <subj-group>
                    <subject>Population Groupings</subject>
                    <subj-group>
                      <subject>Age Groups</subject>
                      <subj-group>
                        <subject>Children</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>People and Places</subject>
                  <subj-group>
                    <subject>Population Groupings</subject>
                    <subj-group>
                      <subject>Families</subject>
                      <subj-group>
                        <subject>Children</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Cell Biology</subject>
                    <subj-group>
                      <subject>Cellular Types</subject>
                      <subj-group>
                        <subject>Animal Cells</subject>
                        <subj-group>
                          <subject>Blood Cells</subject>
                          <subj-group>
                            <subject>White Blood Cells</subject>
                            <subj-group>
                              <subject>Lymphocytes</subject>
                            </subj-group>
                          </subj-group>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Cell Biology</subject>
                    <subj-group>
                      <subject>Cellular Types</subject>
                      <subj-group>
                        <subject>Animal Cells</subject>
                        <subj-group>
                          <subject>Immune Cells</subject>
                          <subj-group>
                            <subject>White Blood Cells</subject>
                            <subj-group>
                              <subject>Lymphocytes</subject>
                            </subj-group>
                          </subj-group>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Immunology</subject>
                    <subj-group>
                      <subject>Immune Cells</subject>
                      <subj-group>
                        <subject>White Blood Cells</subject>
                        <subj-group>
                          <subject>Lymphocytes</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Immunology</subject>
                    <subj-group>
                      <subject>Immune Cells</subject>
                      <subj-group>
                        <subject>White Blood Cells</subject>
                        <subj-group>
                          <subject>Lymphocytes</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and life sciences</subject>
                  <subj-group>
                    <subject>Cell biology</subject>
                    <subj-group>
                      <subject>Cellular types</subject>
                      <subj-group>
                        <subject>Animal cells</subject>
                        <subj-group>
                          <subject>Blood cells</subject>
                          <subj-group>
                            <subject>White blood cells</subject>
                            <subj-group>
                              <subject>NK cells</subject>
                            </subj-group>
                          </subj-group>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and life sciences</subject>
                  <subj-group>
                    <subject>Cell biology</subject>
                    <subj-group>
                      <subject>Cellular types</subject>
                      <subj-group>
                        <subject>Animal cells</subject>
                        <subj-group>
                          <subject>Immune cells</subject>
                          <subj-group>
                            <subject>White blood cells</subject>
                            <subj-group>
                              <subject>NK cells</subject>
                            </subj-group>
                          </subj-group>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and life sciences</subject>
                  <subj-group>
                    <subject>Immunology</subject>
                    <subj-group>
                      <subject>Immune cells</subject>
                      <subj-group>
                        <subject>White blood cells</subject>
                        <subj-group>
                          <subject>NK cells</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and health sciences</subject>
                  <subj-group>
                    <subject>Immunology</subject>
                    <subj-group>
                      <subject>Immune cells</subject>
                      <subj-group>
                        <subject>White blood cells</subject>
                        <subj-group>
                          <subject>NK cells</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Immunology</subject>
                    <subj-group>
                      <subject>Immune Response</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Immunology</subject>
                    <subj-group>
                      <subject>Immune Response</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and health sciences</subject>
                  <subj-group>
                    <subject>Infectious diseases</subject>
                    <subj-group>
                      <subject>Viral diseases</subject>
                      <subj-group>
                        <subject>HIV infections</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Immunology</subject>
                    <subj-group>
                      <subject>Immune System Proteins</subject>
                      <subj-group>
                        <subject>Immune Receptors</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Immunology</subject>
                    <subj-group>
                      <subject>Immune System Proteins</subject>
                      <subj-group>
                        <subject>Immune Receptors</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Biochemistry</subject>
                    <subj-group>
                      <subject>Proteins</subject>
                      <subj-group>
                        <subject>Immune System Proteins</subject>
                        <subj-group>
                          <subject>Immune Receptors</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Cell Biology</subject>
                    <subj-group>
                      <subject>Signal Transduction</subject>
                      <subj-group>
                        <subject>Immune Receptors</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Genetics</subject>
                    <subj-group>
                      <subject>Heredity</subject>
                      <subj-group>
                        <subject>Genetic Mapping</subject>
                        <subj-group>
                          <subject>Variant Genotypes</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Killer Cell Immunoglobulin-Like Receptor Alleles Alter HIV Disease in Children</article-title>
                <alt-title alt-title-type="running-head">KIR/HLA Alleles in HIV Disease in Children</alt-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Singh</surname>
                    <given-names>Kumud K.</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff001">
                    <sup>1</sup>
                  </xref>
                  <xref ref-type="corresp" rid="cor001">*</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Qin</surname>
                    <given-names>Min</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff002">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Brummel</surname>
                    <given-names>Sean S.</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff002">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Angelidou</surname>
                    <given-names>Konstantia</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff002">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Trout</surname>
                    <given-names>Rodney N.</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff001">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Fenton</surname>
                    <given-names>Terence</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff002">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Spector</surname>
                    <given-names>Stephen A.</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff001">
                    <sup>1</sup>
                  </xref>
                  <xref ref-type="aff" rid="aff003">
                    <sup>3</sup>
                  </xref>
                  <xref ref-type="corresp" rid="cor001">*</xref>
                </contrib>
              </contrib-group>
              <aff id="aff001">
                <label>1</label>
                <addr-line>Department of Pediatrics, University of California, San Diego, La Jolla, California, United States of America</addr-line>
              </aff>
              <aff id="aff002">
                <label>2</label>
                <addr-line>Center for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America</addr-line>
              </aff>
              <aff id="aff003">
                <label>3</label>
                <addr-line>Rady Children’s Hospital, San Diego, California, United States of America</addr-line>
              </aff>
              <contrib-group>
                <contrib contrib-type="editor">
                  <name>
                    <surname>Ansari</surname>
                    <given-names>Aftab A.</given-names>
                  </name>
                  <role>Editor</role>
                  <xref ref-type="aff" rid="edit1"/>
                </contrib>
              </contrib-group>
              <aff id="edit1">
                <addr-line>Emory University School of Medicine, UNITED STATES</addr-line>
              </aff>
              <author-notes>
                <fn fn-type="COI-statement" id="coi001">
                  <p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p>
                </fn>
                <fn fn-type="con" id="contrib001">
                  <p>Conceived and designed the experiments: KKS SAS. Performed the experiments: KKS RNT. Analyzed the data: KKS MQ SSB KA TF SAS. Contributed reagents/materials/analysis tools: KKS MQ SSB KA TF SAS. Wrote the paper: KKS MQ SSB KA TF SAS.</p>
                </fn>
                <corresp id="cor001">* E-mail: <email>kusingh@ucsd.edu</email> (KKS); <email>saspector@ucsd.edu</email> (SAS)</corresp>
              </author-notes>
              <pub-date pub-type="epub">
                <day>16</day>
                <month>3</month>
                <year>2016</year>
              </pub-date>
              <pub-date pub-type="collection">
                <year>2016</year>
              </pub-date>
              <volume>11</volume>
              <issue>3</issue>
              <elocation-id>e0151364</elocation-id>
              <history>
                <date date-type="received">
                  <day>14</day>
                  <month>11</month>
                  <year>2015</year>
                </date>
                <date date-type="accepted">
                  <day>27</day>
                  <month>2</month>
                  <year>2016</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© 2016 Singh et al</copyright-statement>
                <copyright-year>2016</copyright-year>
                <copyright-holder>Singh et al</copyright-holder>
                <license xlink:href="http://creativecommons.org/licenses/by/4.0/">
                  <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
                </license>
              </permissions>
              <self-uri content-type="pdf" xlink:type="simple" xlink:href="pone.0151364.pdf"/>
              <abstract>
                <sec id="sec001">
                  <title>Background</title>
                  <p>HLA class I molecules are ligands for killer cell immunoglobin like receptors (KIR) that control the antiviral response of natural killer (NK) cells. However, the effects of <italic>KIR</italic> and <italic>HLA</italic> (<italic>KIR/HLA</italic>) alleles on HIV disease of children have not been studied.</p>
                </sec>
                <sec id="sec002">
                  <title>Methods</title>
                  <p>993 antiretroviral naïve children with symptomatic HIV infection from PACTG protocols P152 and P300 were genotyped for <italic>KIR</italic> and <italic>HLA</italic> alleles using the Luminex platform. Linear regression was used to test the association between genotypes and baseline pre-ART HIV RNA, CD4<sup>+</sup> lymphocyte count, and cognitive score, adjusting for age, race/ethnicity and study. The interaction between genetic markers and age was investigated. To account for multiple testing the false discovery rate (FDR) was controlled at 0.05.</p>
                </sec>
                <sec id="sec003">
                  <title>Results</title>
                  <p>Children with the <italic>KIR2DS4*ALL FULL LENGTH</italic> (<italic>KIR2DS4*AFL</italic>) allele had higher CD4<sup>+</sup> lymphocyte counts. Among children ≤2 years of age, the <italic>KIR2DS4*AFL</italic> was associated with lower plasma HIV RNA and higher cognitive index scores. <italic>KIR Cent2DS3/5_1</italic> had lower CD4<sup>+</sup> lymphocyte counts in children ≤2 years of age, while the presence of <italic>Tel1</italic>, <italic>Tel2DS4_2</italic>, <italic>Tel2DS4_4</italic>, <italic>Tel8</italic>, <italic>Tel2DS4_6</italic> had higher CD4<sup>+</sup> lymphocyte counts in all children. Presence of <italic>Cent2</italic>, <italic>Cent4 and Cent8</italic> was associated with increased HIV RNA load in children ≤2 years. Presence of <italic>KIR3DL1+Bw4</italic> was associated with higher CD4<sup>+</sup> lymphocyte counts in all children. Among children &gt;2 years old, <italic>KIR3DS1+Bw4-80I</italic> was associated with higher plasma HIV RNA, and <italic>Bw6/Bw6</italic> was associated with lower plasma HIV RNA compared to children with <italic>KIR3DS1+Bw4-80I</italic>.</p>
                </sec>
                <sec id="sec004">
                  <title>Conclusions</title>
                  <p>Presented data show for the first time that specific <italic>KIR</italic> alleles independently or combined with HLA ligands are associated with HIV RNA and CD4<sup>+</sup> lymphocyte counts in infected, antiretroviral naive children; and many of these effect estimates appear to be age dependent. These data support a role for specific <italic>KIR</italic> alleles in HIV pathogenesis in children.</p>
                </sec>
              </abstract>
              <funding-group>
                <funding-statement>This research was supported in part by 1R01NS077874 (SAS), UM1AI068616 (MQ, SSB, TF), the International Maternal Perinatal Adolescent AIDS Clinical Trials (IMPAACT) Network. Overall support for the International Maternal Pediatric Adolescent AIDS Clinical Trials Group (IMPAACT) was provided by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) under Award Numbers UM1AI068632 (IMPAACT LOC), UM1AI068616 (IMPAACT SDMC) and UM1AI106716 (IMPAACT LC), with co-funding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the National Institute of Mental Health (NIMH).</funding-statement>
              </funding-group>
              <counts>
                <fig-count count="0"/>
                <table-count count="6"/>
                <page-count count="15"/>
              </counts>
              <custom-meta-group>
                <custom-meta id="data-availability">
                  <meta-name>Data Availability</meta-name>
                  <meta-value>All relevant data are within the paper.</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
            <notes>
              <title>Data Availability</title>
              <p>All relevant data are within the paper.</p>
            </notes>
          </front>
          <body>
            <sec sec-type="intro" id="sec005">
              <title>Introduction</title>
              <p>Natural killer (NK) cells are key components of the innate immune system that act as the first line of defense and regulate antiviral immune responses [<xref rid="pone.0151364.ref001" ref-type="bibr">1</xref>]. NK cells mediate cytotoxicity and cytokine release via a large panel of activating and inhibitory receptors [<xref rid="pone.0151364.ref002" ref-type="bibr">2</xref>, <xref rid="pone.0151364.ref003" ref-type="bibr">3</xref>]. Although human leukocyte antigen (<italic>HLA</italic>) gene products are fundamental to acquired immune responses, they are also important in innate immunity as ligands for the killer cell immunoglobulin-like receptors (KIRs) that modulate NK cell activity [<xref rid="pone.0151364.ref004" ref-type="bibr">4</xref>]. HLA class I molecules closely regulate KIR functions. Both the families of <italic>KIR</italic> and the <italic>HLA</italic> class I genes are extremely diverse suggesting that NK cell mediated innate immune responses are at least partly genetically predetermined [<xref rid="pone.0151364.ref003" ref-type="bibr">3</xref>;<xref rid="pone.0151364.ref005" ref-type="bibr">5</xref>]. KIRs are expressed on both T cells as well as NK cells and may inhibit or activate their function. <italic>HLA</italic> and <italic>KIR</italic> subtype combinations can mount unique innate immune responses against human immunodeficiency virus type-1 (HIV) infection [<xref rid="pone.0151364.ref006" ref-type="bibr">6</xref>]. <italic>HLA</italic> and <italic>KIR</italic> allele combinations can be both protective and deleterious against HIV-related disease progression [<xref rid="pone.0151364.ref007" ref-type="bibr">7</xref>;<xref rid="pone.0151364.ref008" ref-type="bibr">8</xref>] and can affect mother-to-child HIV transmission [<xref rid="pone.0151364.ref009" ref-type="bibr">9</xref>]. Independent and combined <italic>KIR and HLA (KIR/HLA)</italic> genotypes and haplotypes with an activating profile (presence of activating <italic>KIRs</italic> or absence of inhibitory <italic>KIR</italic>s or their respective HLA ligands) have been associated with HIV disease [<xref rid="pone.0151364.ref010" ref-type="bibr">10</xref>–<xref rid="pone.0151364.ref017" ref-type="bibr">17</xref>]. Effects of <italic>KIR/HLA</italic> alleles on HIV disease of children have not been previously studied. In the analyses presented here, we estimated the effects of <italic>KIR</italic> and <italic>HLA</italic> genotypes on plasma HIV RNA, CD4<sup>+</sup> lymphocyte count and cognitive index score using a unique cohort of antiretroviral naïve HIV-infected children.</p>
            </sec>
            <sec id="sec006">
              <title>Subjects and Methods</title>
              <sec id="sec007">
                <title>Participants</title>
                <p>Nine hundred and ninety three antiretroviral naïve children with symptomatic HIV infection from Pediatric AIDS Clinical Trial Group (PACTG) protocols P152 and P300 were included in the analyses [<xref rid="pone.0151364.ref018" ref-type="bibr">18</xref>;<xref rid="pone.0151364.ref019" ref-type="bibr">19</xref>]. P152 and P300 were multicenter, prospective, randomized, double blind, placebo controlled trials that assessed the efficacy of combination nucleoside reverse transcriptase inhibitor (NRTI) treatment regimens in symptomatic HIV-infected children in the United States prior to the availability of effective combination antiretroviral therapy. Important eligibility criteria included children of an age range of 3 months to 18 years with symptomatic HIV infection for P152 [<xref rid="pone.0151364.ref018" ref-type="bibr">18</xref>], and an age range of 42 days to 15 years with symptomatic HIV infection for P300 [<xref rid="pone.0151364.ref019" ref-type="bibr">19</xref>]. In these two protocols, CD4<sup>+</sup> lymphocyte count, plasma HIV RNA and the cognitive score were measured at entry prior to initiation of therapy [<xref rid="pone.0151364.ref018" ref-type="bibr">18</xref>;<xref rid="pone.0151364.ref019" ref-type="bibr">19</xref>].</p>
              </sec>
              <sec id="sec008" sec-type="materials|methods">
                <title>Methods</title>
                <p>Viral load was assayed with the Roche Amplicor quantitative RNA PCR method (limit of detection 400 copies/mL; 2.6 log<sub>10</sub>RNA copies/mL). The age appropriate neuropsychologic evaluations [<xref rid="pone.0151364.ref020" ref-type="bibr">20</xref>] included Bayley (42 days to 36 months) [<xref rid="pone.0151364.ref021" ref-type="bibr">21</xref>]; Wechsler Preschool and Primary Scales of Intelligence-Revised (WPPSI-R, 36 months to 6 years) [<xref rid="pone.0151364.ref022" ref-type="bibr">22</xref>]; Wechsler Intelligence Scale for Children: Revised (WISC-R III, 6 years to 17 years) [<xref rid="pone.0151364.ref023" ref-type="bibr">23</xref>] and Wechsler Adult Intelligence Scale: Revised (WAIS–R, &gt;17 years) [<xref rid="pone.0151364.ref024" ref-type="bibr">24</xref>] for P300. P152 used Bayley scales, McCarthy [<xref rid="pone.0151364.ref025" ref-type="bibr">25</xref>] scales, WISC- R and WAIS–R as age appropriate. All cognitive scores were standardized (mean = 100, SD = 16). Children having a cognitive score below 70 are typically considered impaired. Studies followed the human experimentation guidelines of the US Department of Health and Human Services. The University of California San Diego Institutional Review Board has approved this study. Parents or legal guardians provided written informed consent to participate in these studies. Written informed consent had to be signed prior to participation in the studies. Each participating site was required to have Institutional Review Board approval prior to initiating the studies at their site.</p>
              </sec>
              <sec id="sec009">
                <title>Genotyping</title>
                <p>Stored DNA samples from the 993 children were assayed for <italic>KIR</italic> alleles using LIFECODES KIR-SSO TYPING KIT on the Luminex platform (Kashi Clinical Laboratories, Inc. Portland, OR). Total genomic DNA was extracted from peripheral blood mononuclear cells (PBMCs) using QIAamp DNA Blood Mini Kit (Qiagen, Carlsbad, CA). Whole genome amplification of DNA was done using Qiagen WGA kits [<xref rid="pone.0151364.ref026" ref-type="bibr">26</xref>]. The following KIR allelic variants were genotyped: <italic>2DL1</italic>, <italic>2DL2 (2DL2*001/2/3/5</italic>, <italic>2DL2*004)</italic>, <italic>2DL3</italic>, <italic>2DL4</italic>, <italic>2DL5</italic>, <italic>2DS1</italic>, <italic>2DS2</italic>, <italic>2DS3</italic>, <italic>2DS4*</italic> ALL FULL LENGTH (AFL), <italic>2DS4</italic>*deletion exon 5 (Ex.5), <italic>2DS4</italic>*full length exon 5 (Ex.5), <italic>2DS5</italic>, <italic>3DL1</italic>, <italic>3DL2</italic>, <italic>3DL3</italic>, <italic>3DS1</italic>, <italic>3DS1*49N</italic>, <italic>2DP1</italic>, and 3DP1. <italic>KIR2DS4</italic>*AFL probe confirmed the presence of the full length <italic>KIR2DS4</italic> gene, while the subsequent two probes further characterized the exon 5 such that <italic>KIR2DS4</italic>*deletion Ex.5 represented a deletion in exon 5 while <italic>KIR2DS4</italic>*full length Ex.5 represented no deletion in exon 5. Pseudogenes (<italic>KIR3DP1</italic> and <italic>KIR2DP1</italic>) that do not code functional KIR receptors were excluded from the analyses. Delimiting alleles <italic>KIR2DL4</italic> and <italic>KIR3DL3</italic> were positive in all children and were therefore excluded from the analyses.</p>
                <p>The <italic>KIR</italic> locus on chromosome 19 was split into the centromeric (Cent) and telomeric (Tel) regions and analyzed as described earlier [<xref rid="pone.0151364.ref027" ref-type="bibr">27</xref>]. KIR centromeric alleles (Cent 1–9) included <italic>2DS2</italic>, <italic>2DL2</italic>, <italic>2DL3</italic>, <italic>2DL1</italic>; telomeric alleles (Tel 1–8) included <italic>3DS1</italic>, <italic>2DS1</italic>, <italic>3DL1</italic>, <italic>2DS4</italic> and combined centromeric and telomeric (Cent/Tel) alleles included <italic>2DL5</italic>, <italic>2DS3</italic>, and <italic>2DS5</italic>. The Cent/Tel KIR motif with <italic>KIR2DL5</italic> variants are grouped in 13 different loci, the Cent KIR motif with <italic>KIR2DL1</italic> and <italic>KIR2DS3/KIR2DS5</italic> genes were grouped in 8 different loci (Cent-<italic>2DS3/5 1–8</italic>), and the Tel <italic>KIR</italic> motif with <italic>KIR2DS4</italic> Full/del variant subtypes were grouped in 8 different loci (Tel-<italic>2DS4</italic> 1–8). Activating KIR alleles included <italic>2DS4</italic>, <italic>2DS1</italic>, <italic>2DS2</italic>, <italic>2DS3/2DS5</italic>, <italic>3DS1</italic> and inhibiting alleles include <italic>2DL5A</italic>, <italic>3DL1</italic>, <italic>2DL1</italic>, <italic>2DL5B</italic>, <italic>2DL2/2DL3</italic>. <italic>KIR2DL4</italic> encodes a receptor that has both inhibitory [<xref rid="pone.0151364.ref028" ref-type="bibr">28</xref>] and activating functions [<xref rid="pone.0151364.ref029" ref-type="bibr">29</xref>;<xref rid="pone.0151364.ref030" ref-type="bibr">30</xref>]. HLA genotyping was performed using Lifecodes HLA SSO (Immuncor, Norcross, GA) by multiplexing using Luminex 100 platform (Luminex Corp, Austin, TX) at Tepnel Lifecodes Corporation (Stamford, CT) for <italic>HLA-A</italic>, <italic>B</italic>, <italic>C</italic>, <italic>HLA DRB</italic> alleles, as previously described [<xref rid="pone.0151364.ref031" ref-type="bibr">31</xref>]. For considering HLA-C molecules as ligands of NK cells, all <italic>HLA-C</italic> alleles can be grouped in two major KIR epitopes, <italic>HLA-C*01/*03/*07/*08/*12/*14/*16</italic> alleles as <italic>HLA-C1</italic> group and <italic>HLA-C*02/*04/*05/*06/*15/*17/*18</italic> alleles as <italic>HLA-C2</italic> group [<xref rid="pone.0151364.ref032" ref-type="bibr">32</xref>]. HLA-C1 molecules are ligands for inhibitory KIR2DL2/3 and activating KIR2DS2 receptors; and HLA-C2 molecules are ligands for inhibitory KIR2DL1 and activating KIR2DS1 receptors [<xref rid="pone.0151364.ref033" ref-type="bibr">33</xref>, <xref rid="pone.0151364.ref034" ref-type="bibr">34</xref>].</p>
              </sec>
              <sec id="sec010">
                <title>Statistical methods</title>
                <p>Individual KIR genotypes and haplotypes [<xref rid="pone.0151364.ref035" ref-type="bibr">35</xref>] were analyzed for their association with HIV disease. Additionally, KIR and HLA alleles were analyzed independently and in combination (including previously reported KIR3DL1, KIR3DS1 with Bw4, Bw4-80I or Bw4-80T alleles) [<xref rid="pone.0151364.ref006" ref-type="bibr">6</xref>–<xref rid="pone.0151364.ref008" ref-type="bibr">8</xref>] for their effects on immunological, virological and neurocognitive outcomes. An indicator variable was created to indicate the joint presence of specific KIR and HLA alleles. In HLA-Bw6/Bw6 individuals, it does not matter which KIR3DL1 subtype is present because the ligand Bw4 is absent, and KIR3DL1 molecule is non-functional in these individuals. The Bw6/Bw6 group was also used as a control group for the analysis of the KIR subtypes.</p>
                <p>Multivariable linear regression was used to test the association between the <italic>KIR</italic> and <italic>HLA</italic> allelic variants, and three baseline outcome measures: HIV RNA load, CD4<sup>+</sup> lymphocyte count, and cognitive score. In order to correct for heterogeneity of variance, the robust variance estimator was used [<xref rid="pone.0151364.ref036" ref-type="bibr">36</xref>]. As children ≤2 years of age often have more rapid disease progression than those older than 2 years and have more immature immune systems, it was hypothesized that the effects of host genetics on HIV disease may vary with age. Therefore, the interaction between each genetic marker and age group (age ≤2 years and &gt;2 years) was investigated. For genetic markers with a marginally significant (p &lt;0.1) genotype by age (age ≤2 years and &gt;2 years) interaction, regression models were fit to each age group separately. Potential confounders that were included in the adjusted analyses were determined <italic>a-priori</italic> and included age, race/ethnicity and study (P152 vs. P300).</p>
                <p>To control the false discovery rate (FDR), we used methods developed by Benjamini and Hochberg [<xref rid="pone.0151364.ref037" ref-type="bibr">37</xref>] and evaluated the results with the FDR value set at 0.1, as well as 0.05. All genetic associations with a p-value &lt;0.05 in adjusted models were included in the summary tables along with the corresponding 95% confidence intervals (CI). Associations with an FDR &lt;0.05 were considered to be statistically significant, while those with an FDR between 0.05 and 0.1 were considered to be marginally significant.</p>
              </sec>
            </sec>
            <sec sec-type="results" id="sec011">
              <title>Results</title>
              <sec id="sec012">
                <title>Baseline characteristics</title>
                <p>Of the 993 antiretroviral naïve children with symptomatic HIV infection, 430 (43%) were from P152 and 563 (57%) from P300; 453 (46%) were male. The median age was 2.3 years with 605 (61%) identified as Black, 245 (25%) Hispanic, 127 (13%) White and 16 (2%) as ‘Others’ race/ethnicity. Of the 986 subjects with baseline CD4<sup>+</sup> lymphocyte counts, the median baseline CD4<sup>+</sup> lymphocyte count was 778 count/mm<sup>3</sup>; 825 subjects had baseline HIV RNA data with a median baseline log<sub>10</sub> RNA of 5.14. Of the 935 subjects with available baseline cognitive scores, the median baseline score was 83. Detailed characteristics of this population are provided in <bold><xref rid="pone.0151364.t001" ref-type="table">Table 1</xref></bold>.</p>
                <table-wrap id="pone.0151364.t001" orientation="portrait" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0151364.t001</object-id>
                  <label>Table 1</label>
                  <caption>
                    <title>Baseline characteristics.</title>
                  </caption>
                  <alternatives>
                    <graphic id="pone.0151364.t001g" xlink:href="pone.0151364.t001"/>
                    <table frame="hsides" rules="groups">
                      <colgroup span="1">
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                      </colgroup>
                      <thead>
                        <tr>
                          <th align="left" colspan="2" rowspan="1">Characteristics</th>
                          <th align="left" rowspan="1" colspan="1">Total (N = 993)</th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Gender</td>
                          <td align="left" rowspan="1" colspan="1">Male</td>
                          <td align="left" rowspan="1" colspan="1">453 (46%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">Female</td>
                          <td align="left" rowspan="1" colspan="1">540 (54%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Study</td>
                          <td align="left" rowspan="1" colspan="1">152</td>
                          <td align="left" rowspan="1" colspan="1">430 (43%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">300</td>
                          <td align="left" rowspan="1" colspan="1">563 (57%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Race</td>
                          <td align="left" rowspan="1" colspan="1">Black</td>
                          <td align="left" rowspan="1" colspan="1">605 (61%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">Hispanic</td>
                          <td align="left" rowspan="1" colspan="1">245 (25%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">White</td>
                          <td align="left" rowspan="1" colspan="1">127 (13%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">Other</td>
                          <td align="left" rowspan="1" colspan="1">16 (2%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Age (years)</td>
                          <td align="left" rowspan="1" colspan="1">N</td>
                          <td align="left" rowspan="1" colspan="1">993</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">Mean (s.d.)</td>
                          <td align="left" rowspan="1" colspan="1">3.77 (3.84)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">Median (Q1, Q3)</td>
                          <td align="left" rowspan="1" colspan="1">2.31 (0.84, 5.56)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">(0, 2]</td>
                          <td align="left" rowspan="1" colspan="1">460 (46%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">(2, 18)</td>
                          <td align="left" rowspan="1" colspan="1">533 (54%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Baseline CD4<sup>+</sup> lymphocyte count (cells/mm<sup>3</sup>)</td>
                          <td align="left" rowspan="1" colspan="1">N</td>
                          <td align="left" rowspan="1" colspan="1">986</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">Mean (s.d.)</td>
                          <td align="left" rowspan="1" colspan="1">981.31 (838.84)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">Median (Q1, Q3)</td>
                          <td align="left" rowspan="1" colspan="1">777.96 (412.45, 1,318.83)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Baseline CD4<sup>+</sup> lymphocyte percent</td>
                          <td align="left" rowspan="1" colspan="1">Mean (s.d.)</td>
                          <td align="left" rowspan="1" colspan="1">23.71 (11.98)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">Median (Q1, Q3)</td>
                          <td align="left" rowspan="1" colspan="1">23.92 (16.00, 31.00)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Baseline plasma HIV RNA (copies/ml)</td>
                          <td align="left" rowspan="1" colspan="1">N</td>
                          <td align="left" rowspan="1" colspan="1">825</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">Mean (s.d.)</td>
                          <td align="left" rowspan="1" colspan="1">868,428 (2,465,255)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">Median (Q1, Q3)</td>
                          <td align="left" rowspan="1" colspan="1">139,476 (33,000,510,000)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Baseline log<sub>10</sub> plasma HIV RNA (copies/ml)</td>
                          <td align="left" rowspan="1" colspan="1">Mean (s.d.)</td>
                          <td align="left" rowspan="1" colspan="1">5.10 (0.94)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">Median (Q1, Q3)</td>
                          <td align="left" rowspan="1" colspan="1">5.14</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Baseline cognitive score</td>
                          <td align="left" rowspan="1" colspan="1">N</td>
                          <td align="left" rowspan="1" colspan="1">935</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">Mean (s.d.)</td>
                          <td align="left" rowspan="1" colspan="1">81.73 (17.63)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">Median (Q1, Q3)</td>
                          <td align="left" rowspan="1" colspan="1">83</td>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                </table-wrap>
                <p>Distribution of <italic>KIR</italic> alleles, centromeric (<italic>Cent</italic>), telomeric (<italic>Tel</italic>) and combined <italic>Cent/Tel</italic> alleles and combined <italic>KIR/HLA</italic> alleles in the studied cohort are listed in <bold>Tables <xref rid="pone.0151364.t002" ref-type="table">2</xref>, <xref rid="pone.0151364.t003" ref-type="table">3</xref> and <xref rid="pone.0151364.t004" ref-type="table">4</xref></bold>.</p>
                <table-wrap id="pone.0151364.t002" orientation="portrait" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0151364.t002</object-id>
                  <label>Table 2</label>
                  <caption>
                    <title>Frequency of <italic>KIR</italic> alleles.</title>
                  </caption>
                  <alternatives>
                    <graphic id="pone.0151364.t002g" xlink:href="pone.0151364.t002"/>
                    <table frame="hsides" rules="groups">
                      <colgroup span="1">
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                      </colgroup>
                      <thead>
                        <tr>
                          <th align="left" rowspan="1" colspan="1"><italic>KIR</italic> Genotypes</th>
                          <th align="left" rowspan="1" colspan="1">N (% Positive)</th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <italic>KIR2DL1</italic>
                          </td>
                          <td align="left" rowspan="1" colspan="1">966 (97%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <italic>KIR2DL3</italic>
                          </td>
                          <td align="left" rowspan="1" colspan="1">719 (72%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <italic>KIR2DL4</italic>
                          </td>
                          <td align="left" rowspan="1" colspan="1">993 (100%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <italic>KIR2DL5</italic>
                          </td>
                          <td align="left" rowspan="1" colspan="1">547 (55%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <italic>KIR2DL2*004</italic>
                          </td>
                          <td align="left" rowspan="1" colspan="1">31 (3%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <italic>KIR2DL2*001/2/3/5</italic>
                          </td>
                          <td align="left" rowspan="1" colspan="1">544 (55%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <italic>KIR2DP1</italic>
                          </td>
                          <td align="left" rowspan="1" colspan="1">964 (97%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <italic>KIR2DS1</italic>
                          </td>
                          <td align="left" rowspan="1" colspan="1">284 (29%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <italic>KIR2DS2</italic>
                          </td>
                          <td align="left" rowspan="1" colspan="1">527 (53%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <italic>KIR2DS3</italic>
                          </td>
                          <td align="left" rowspan="1" colspan="1">290 (29%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <italic>KIR2DS5</italic>
                          </td>
                          <td align="left" rowspan="1" colspan="1">344 (35%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <italic>KIR 2DS4*all full length</italic>
                          </td>
                          <td align="left" rowspan="1" colspan="1">957 (96%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <italic>KIR 2DS4*deletion ex5</italic>
                          </td>
                          <td align="left" rowspan="1" colspan="1">660 (66%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <italic>KIR 2DS4*full length ex5</italic>
                          </td>
                          <td align="left" rowspan="1" colspan="1">598 (60%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <italic>KIR3DL1</italic>
                          </td>
                          <td align="left" rowspan="1" colspan="1">936 (94%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <italic>KIR3DL2</italic>
                          </td>
                          <td align="left" rowspan="1" colspan="1">992 (99%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <italic>KIR3DL3</italic>
                          </td>
                          <td align="left" rowspan="1" colspan="1">993 (100%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <italic>KIR3DP1</italic>
                          </td>
                          <td align="left" rowspan="1" colspan="1">993 (100%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <italic>KIR3DS1</italic>
                          </td>
                          <td align="left" rowspan="1" colspan="1">224 (23%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <italic>KIR3DS1/49</italic>
                          </td>
                          <td align="left" rowspan="1" colspan="1">6 (1%)</td>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                </table-wrap>
                <table-wrap id="pone.0151364.t003" orientation="portrait" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0151364.t003</object-id>
                  <label>Table 3</label>
                  <caption>
                    <title>Frequency of the <italic>KIR</italic> centromeric/telomeric alleles.</title>
                  </caption>
                  <alternatives>
                    <graphic id="pone.0151364.t003g" xlink:href="pone.0151364.t003"/>
                    <table frame="hsides" rules="groups">
                      <colgroup span="1">
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                      </colgroup>
                      <thead>
                        <tr>
                          <th align="left" rowspan="1" colspan="1">Centromeric/Telomeric alleles<xref ref-type="table-fn" rid="t003fn001">*</xref></th>
                          <th align="left" rowspan="1" colspan="1">N (% Positive)</th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"><italic>Cent1</italic>: <italic>2DL1/2DL3</italic></td>
                          <td align="left" rowspan="1" colspan="1">719 (72%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"><italic>Cent2</italic>: <italic>2DL1/2DL3/2DL2/2DS2</italic></td>
                          <td align="left" rowspan="1" colspan="1">323 (33%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"><italic>Cent3</italic>: <italic>2DL1/2DL3/2DL2</italic></td>
                          <td align="left" rowspan="1" colspan="1">351 (35%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"><italic>Cent4</italic>: <italic>2DL1/2DL3/2DS2</italic></td>
                          <td align="left" rowspan="1" colspan="1">329 (33%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"><italic>Cent5</italic>: <italic>2DL1/2DL2</italic></td>
                          <td align="left" rowspan="1" colspan="1">535 (54%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"><italic>Cent6</italic>: <italic>2DL1/2DL2/2DS2</italic></td>
                          <td align="left" rowspan="1" colspan="1">494 (50%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"><italic>Cent7</italic>: <italic>2DL2/2DS2</italic></td>
                          <td align="left" rowspan="1" colspan="1">520 (52%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"><italic>Cent8</italic>: <italic>2DL2/2DL3/2DS2</italic></td>
                          <td align="left" rowspan="1" colspan="1">323 (33%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"><italic>Cent9</italic>: <italic>2DL3</italic></td>
                          <td align="left" rowspan="1" colspan="1">719 (72%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"><italic>Cent-2DS3/5(1)</italic>: <italic>2DS3/2DS5/2DL1</italic></td>
                          <td align="left" rowspan="1" colspan="1">89 (9%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"><italic>Cent-2DS3/5(2)</italic>: <italic>2DS5/2DL1</italic></td>
                          <td align="left" rowspan="1" colspan="1">330 (33%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"><italic>Cent-2DS3/5(3)</italic>: <italic>2DS3/2DL1</italic></td>
                          <td align="left" rowspan="1" colspan="1">289 (29%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"><italic>Cent-2DS3/5(4)</italic>: <italic>2DL1</italic></td>
                          <td align="left" rowspan="1" colspan="1">966 (97%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"><italic>Cent-2DS3/5(5)</italic>: <italic>2DS3/2DS5</italic></td>
                          <td align="left" rowspan="1" colspan="1">89 (9%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"><italic>Cent-2DS3/5(6)</italic>: <italic>2DS5</italic></td>
                          <td align="left" rowspan="1" colspan="1">344 (35%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"><italic>Cent-2DS3/5(7) or Cent/Tel4</italic>: <italic>2DS3</italic></td>
                          <td align="left" rowspan="1" colspan="1">290 (29%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"><italic>Cent-2DS3/5(8)</italic>: <italic>none of 2DS3/2DS5/2DL1</italic></td>
                          <td align="left" rowspan="1" colspan="1">12 (1%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"><italic>Tel1</italic>: <italic>2DS4_ALL_FULL_LENGTH/3DL1</italic></td>
                          <td align="left" rowspan="1" colspan="1">924 (93%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"><italic>Tel2</italic>: <italic>2DS4_ALL_FULL_LENGTH/3DL1/2DS1/3DS1</italic></td>
                          <td align="left" rowspan="1" colspan="1">174 (18%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"><italic>Tel3</italic>: <italic>2DS4_ALL_FULL_LENGTH/3DL1/2DS1</italic></td>
                          <td align="left" rowspan="1" colspan="1">238 (24%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"><italic>Tel4</italic>: <italic>2DS4_ALL_FULL_LENGTH/3DL1/3DS1</italic></td>
                          <td align="left" rowspan="1" colspan="1">190 (19%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"><italic>Tel5</italic>: <italic>2DS4_ALL_FULL_LENGTH/3DS1/2DS1</italic></td>
                          <td align="left" rowspan="1" colspan="1">179 (18%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"><italic>Tel6</italic>: <italic>3DS1/2DS1</italic></td>
                          <td align="left" rowspan="1" colspan="1">207 (21%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"><italic>Tel7</italic>: <italic>2DS4_ALL_FULL_LENGTH</italic></td>
                          <td align="left" rowspan="1" colspan="1">957 (96%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"><italic>Tel8 or Tel-2DS4(4)</italic>: <italic>3DL1</italic></td>
                          <td align="left" rowspan="1" colspan="1">936 (94%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"><italic>Tel-2DS4(1)</italic>: <italic>2DS4_AFL+Del/3DL1</italic></td>
                          <td align="left" rowspan="1" colspan="1">637 (64%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"><italic>Tel-2DS4(2)</italic>: <italic>2DS4_AFL/3DL1</italic></td>
                          <td align="left" rowspan="1" colspan="1">924 (93%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"><italic>Tel-2DS4(3)</italic>: <italic>2DS4_ALL_Del/3DL1</italic></td>
                          <td align="left" rowspan="1" colspan="1">637 (64%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"><italic>Tel-2DS4(5)</italic>: <italic>2DS4_ALL_FULL_LENGTH+Del</italic></td>
                          <td align="left" rowspan="1" colspan="1">660 (66%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"><italic>Tel-2DS4(6)</italic>: <italic>2DS4_ALL_FULL_LENGTH</italic></td>
                          <td align="left" rowspan="1" colspan="1">957 (96%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"><italic>Tel-2DS4(7)</italic>: <italic>2DS4_Del</italic></td>
                          <td align="left" rowspan="1" colspan="1">660 (66%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"><italic>Cent/Tel1</italic>: <italic>2DS3/2DS5/2DL5</italic></td>
                          <td align="left" rowspan="1" colspan="1">89 (9%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"><italic>Cent/Tel2</italic>: <italic>2DS5/2DL5</italic></td>
                          <td align="left" rowspan="1" colspan="1">331 (33%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"><italic>Cent/Tel3</italic>: <italic>2DS3/2DL5</italic></td>
                          <td align="left" rowspan="1" colspan="1">290 (29%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"><italic>Cent/Tel5</italic>: <italic>2DL5</italic></td>
                          <td align="left" rowspan="1" colspan="1">547 (55%)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"><italic>Cent/Tel6</italic>: <italic>none of 2DS3/2DS5/2DL5</italic></td>
                          <td align="left" rowspan="1" colspan="1">433 (44%)</td>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                  <table-wrap-foot>
                    <fn id="t003fn001">
                      <p>*9 KIR centromeric alleles (Cent 1–9) included <italic>2DS2</italic>, <italic>2DL1</italic>, <italic>2DL2</italic>, <italic>2DL3</italic>; 8 telomeric alleles (Tel 1–8) included <italic>3DS1</italic>, <italic>2DS1</italic>, <italic>3DL1</italic>, <italic>2DS4</italic> and combined centromeric and telomeric (Cent/Tel) alleles included <italic>2DL5</italic>, <italic>2DS3</italic>, and <italic>2DS5</italic>. The Cent allele with <italic>KIR2DL1</italic> and <italic>KIR2DS3/KIR2DS5</italic> genes were grouped in 8 different loci (Cent-<italic>2DS3/5</italic>, <italic>1–8</italic>), and the Tel allele with <italic>KIR2DS4</italic> Full/del variant subtypes were grouped in 8 different loci (Tel-<italic>2DS4</italic>, 1–8).</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
                <table-wrap id="pone.0151364.t004" orientation="portrait" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0151364.t004</object-id>
                  <label>Table 4</label>
                  <caption>
                    <title>Frequency of the <italic>KIR/HLA</italic> alleles.</title>
                  </caption>
                  <alternatives>
                    <graphic id="pone.0151364.t004g" xlink:href="pone.0151364.t004"/>
                    <table frame="hsides" rules="groups">
                      <colgroup span="1">
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                      </colgroup>
                      <thead>
                        <tr>
                          <th align="center" rowspan="1" colspan="1"><italic>KIR/HLA</italic> Genotypes</th>
                          <th align="center" rowspan="1" colspan="1">Genotype Analysis Combinations</th>
                          <th align="center" rowspan="1" colspan="1">N (%)</th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">
                            <italic>Bw4/Bw6</italic>
                          </td>
                          <td align="center" rowspan="1" colspan="1">
                            <italic>Bw4/Bw4</italic>
                          </td>
                          <td align="center" rowspan="1" colspan="1">278 (29%)</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1">
                            <italic>Bw4/Bw6</italic>
                          </td>
                          <td align="center" rowspan="1" colspan="1">471 (49%)</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1">
                            <italic>Bw6/Bw6</italic>
                          </td>
                          <td align="center" rowspan="1" colspan="1">220 (23%)</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">
                            <italic>KIR3DL1+Bw4</italic>
                          </td>
                          <td align="center" rowspan="1" colspan="1">
                            <italic>3DL1+Bw4</italic>
                          </td>
                          <td align="center" rowspan="1" colspan="1">626 (63%)</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1">
                            <italic>Bw6/Bw6</italic>
                          </td>
                          <td align="center" rowspan="1" colspan="1">310 (31%)</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1">
                            <italic>Non-3DL1+Bw4</italic>
                          </td>
                          <td align="center" rowspan="1" colspan="1">57 (6%)</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">
                            <italic>KIR3DL1+Bw4-80I</italic>
                          </td>
                          <td align="center" rowspan="1" colspan="1">
                            <italic>3DL1+Bw4-80I</italic>
                          </td>
                          <td align="center" rowspan="1" colspan="1">398 (40%)</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1">
                            <italic>Bw6/Bw6</italic>
                          </td>
                          <td align="center" rowspan="1" colspan="1">310 (31%)</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1">
                            <italic>Non-3DL1+Bw4-80I</italic>
                          </td>
                          <td align="center" rowspan="1" colspan="1">285 (29%)</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">
                            <italic>KIR3DL1+Bw4-80T</italic>
                          </td>
                          <td align="center" rowspan="1" colspan="1">
                            <italic>3DL1+Bw4-80T</italic>
                          </td>
                          <td align="center" rowspan="1" colspan="1">229 (23%)</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1">
                            <italic>Bw6/Bw6</italic>
                          </td>
                          <td align="center" rowspan="1" colspan="1">310 (31%)</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1">
                            <italic>Non-3DL1+Bw4-80T</italic>
                          </td>
                          <td align="center" rowspan="1" colspan="1">454 (46%)</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">
                            <italic>KIR3DS1+Bw4</italic>
                          </td>
                          <td align="center" rowspan="1" colspan="1">
                            <italic>3DS1+Bw4</italic>
                          </td>
                          <td align="center" rowspan="1" colspan="1">143 (14%)</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1">
                            <italic>Bw6/Bw6</italic>
                          </td>
                          <td align="center" rowspan="1" colspan="1">310 (31%)</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1">
                            <italic>Non-3DS1+Bw4</italic>
                          </td>
                          <td align="center" rowspan="1" colspan="1">540 (54%)</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">
                            <italic>KIR3DS1+Bw4-80I</italic>
                          </td>
                          <td align="center" rowspan="1" colspan="1">
                            <italic>3DS1+Bw4-80I</italic>
                          </td>
                          <td align="center" rowspan="1" colspan="1">79 (8%)</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1">
                            <italic>Bw6/Bw6</italic>
                          </td>
                          <td align="center" rowspan="1" colspan="1">310 (31%)</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1">
                            <italic>Non-3DS1+Bw4-80I</italic>
                          </td>
                          <td align="center" rowspan="1" colspan="1">604 (61%)</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">
                            <italic>KIR3DL1+B27/B57/Bw4-80I/Bw4-80T</italic>
                          </td>
                          <td align="center" rowspan="1" colspan="1">
                            <italic>3DL1+B27/B57/Bw4-80I/Bw4-80T</italic>
                          </td>
                          <td align="center" rowspan="1" colspan="1">564 (57%)</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1">
                            <italic>Bw6/Bw6</italic>
                          </td>
                          <td align="center" rowspan="1" colspan="1">310 (31%)</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1">
                            <italic>Non-3DL1+B27/B57/Bw4-80I/Bw4-80T</italic>
                          </td>
                          <td align="center" rowspan="1" colspan="1">119 (12%)</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">
                            <italic>KIR3DL1+Bw4/Bw4-80I/Bw4-80T</italic>
                          </td>
                          <td align="center" rowspan="1" colspan="1">
                            <italic>3DL1+Bw4/Bw4-80I/Bw4-80T</italic>
                          </td>
                          <td align="center" rowspan="1" colspan="1">626 (63%)</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1">
                            <italic>Bw6/Bw6</italic>
                          </td>
                          <td align="center" rowspan="1" colspan="1">310 (31%)</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1">
                            <italic>Non-3DL1+Bw4/Bw4-80I/Bw4-80T</italic>
                          </td>
                          <td align="center" rowspan="1" colspan="1">57 (6%)</td>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                </table-wrap>
              </sec>
              <sec id="sec013">
                <title>Associations of KIR and HLA alleles with baseline CD4<sup>+</sup> lymphocyte counts</title>
                <p>Results of association of independent and combined <italic>KIR</italic> and <italic>HLA</italic> alleles with CD4<sup>+</sup> lymphocyte counts are summarized in <bold><xref rid="pone.0151364.t005" ref-type="table">Table 5</xref></bold>.</p>
                <table-wrap id="pone.0151364.t005" orientation="portrait" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0151364.t005</object-id>
                  <label>Table 5</label>
                  <caption>
                    <title>Association of <italic>KIR/HLA</italic> alleles with baseline CD4<sup>+</sup> lymphocyte count.</title>
                  </caption>
                  <alternatives>
                    <graphic id="pone.0151364.t005g" xlink:href="pone.0151364.t005"/>
                    <table frame="hsides" rules="groups">
                      <colgroup span="1">
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                      </colgroup>
                      <thead>
                        <tr>
                          <th align="center" colspan="6" rowspan="1">Characteristics</th>
                          <th align="center" colspan="2" rowspan="1">Unadjusted Analysis</th>
                          <th align="center" colspan="3" rowspan="1">Adjusted Analysis</th>
                        </tr>
                        <tr>
                          <th align="left" rowspan="1" colspan="1">SNP Type</th>
                          <th align="left" rowspan="1" colspan="1">SNP</th>
                          <th align="left" rowspan="1" colspan="1">Age by Genotype Interaction</th>
                          <th align="left" rowspan="1" colspan="1">Age Group</th>
                          <th align="left" rowspan="1" colspan="1">Level</th>
                          <th align="left" rowspan="1" colspan="1">Count</th>
                          <th align="left" rowspan="1" colspan="1">Difference (LCI, UCI)</th>
                          <th align="left" rowspan="1" colspan="1">P-value</th>
                          <th align="left" rowspan="1" colspan="1">Difference (LCI,UCI)</th>
                          <th align="left" rowspan="1" colspan="1">P-value</th>
                          <th align="left" rowspan="1" colspan="1">FDR Significance</th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <italic>KIR</italic>
                          </td>
                          <td align="left" rowspan="1" colspan="1">
                            <italic>KIR 2DL2_004</italic>
                          </td>
                          <td align="left" rowspan="1" colspan="1">0.44</td>
                          <td align="left" rowspan="1" colspan="1">All</td>
                          <td align="left" rowspan="1" colspan="1">Positive</td>
                          <td align="left" rowspan="1" colspan="1">31</td>
                          <td align="left" rowspan="1" colspan="1">-227(-428,-27)</td>
                          <td align="left" rowspan="1" colspan="1">0.0264</td>
                          <td align="left" rowspan="1" colspan="1">-204(-384,-25)</td>
                          <td align="left" rowspan="1" colspan="1">0.0259</td>
                          <td align="center" rowspan="1" colspan="1">
                            <xref ref-type="table-fn" rid="t005fn004">-</xref>
                          </td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">Negative (Ref)</td>
                          <td align="left" rowspan="1" colspan="1">955</td>
                          <td align="left" rowspan="1" colspan="1">989(935,1042)</td>
                          <td align="left" rowspan="1" colspan="1">.</td>
                          <td align="left" rowspan="1" colspan="1">1379(1278,1480)</td>
                          <td align="left" rowspan="1" colspan="1">.</td>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">
                            <italic>KIR 2DS4_AFL</italic>
                          </td>
                          <td align="left" rowspan="1" colspan="1">0.19</td>
                          <td align="left" rowspan="1" colspan="1">All</td>
                          <td align="left" rowspan="1" colspan="1">Positive</td>
                          <td align="left" rowspan="1" colspan="1">950</td>
                          <td align="left" rowspan="1" colspan="1">279(112,447)</td>
                          <td align="left" rowspan="1" colspan="1">0.0011</td>
                          <td align="left" rowspan="1" colspan="1">265(103,426)</td>
                          <td align="left" rowspan="1" colspan="1">0.0013</td>
                          <td align="center" rowspan="1" colspan="1">
                            <xref ref-type="table-fn" rid="t005fn006">**</xref>
                          </td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">Negative(Ref)</td>
                          <td align="left" rowspan="1" colspan="1">36</td>
                          <td align="left" rowspan="1" colspan="1">712 (554,871)</td>
                          <td align="left" rowspan="1" colspan="1">.</td>
                          <td align="left" rowspan="1" colspan="1">1122 (952,1293)</td>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">
                            <italic>KIR 3DL1 (Tel 8)</italic>
                          </td>
                          <td align="left" rowspan="1" colspan="1">0.91</td>
                          <td align="left" rowspan="1" colspan="1">All</td>
                          <td align="left" rowspan="1" colspan="1">Positive</td>
                          <td align="left" rowspan="1" colspan="1">929</td>
                          <td align="left" rowspan="1" colspan="1">227(42,412)</td>
                          <td align="left" rowspan="1" colspan="1">0.0160</td>
                          <td align="left" rowspan="1" colspan="1">218(49,386)</td>
                          <td align="left" rowspan="1" colspan="1">0.0113</td>
                          <td align="center" rowspan="1" colspan="1">
                            <xref ref-type="table-fn" rid="t005fn005">*</xref>
                          </td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">Negative(Ref)</td>
                          <td align="left" rowspan="1" colspan="1">57</td>
                          <td align="left" rowspan="1" colspan="1">767 (591,944)</td>
                          <td align="left" rowspan="1" colspan="1">.</td>
                          <td align="left" rowspan="1" colspan="1">1170(985,1355)</td>
                          <td align="left" rowspan="1" colspan="1">.</td>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"><italic>KIR</italic>centromeric/telomeric</td>
                          <td align="left" rowspan="1" colspan="1">
                            <italic>Cent-2DS3/5(1):2DS3/2DS5/2DL1<xref ref-type="table-fn" rid="t005fn003">#</xref></italic>
                          </td>
                          <td align="left" rowspan="1" colspan="1">0.08</td>
                          <td align="left" rowspan="1" colspan="1">(0, 2]</td>
                          <td align="left" rowspan="1" colspan="1">Positive</td>
                          <td align="left" rowspan="1" colspan="1">36</td>
                          <td align="left" rowspan="1" colspan="1">-406(-646,-166)</td>
                          <td align="left" rowspan="1" colspan="1">0.0009</td>
                          <td align="left" rowspan="1" colspan="1">-431(-676,-185)</td>
                          <td align="left" rowspan="1" colspan="1">0.0006</td>
                          <td align="center" rowspan="1" colspan="1">
                            <xref ref-type="table-fn" rid="t005fn006">**</xref>
                          </td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">Negative(Ref)</td>
                          <td align="left" rowspan="1" colspan="1">419</td>
                          <td align="left" rowspan="1" colspan="1">1426(1329,1523)</td>
                          <td align="left" rowspan="1" colspan="1">.</td>
                          <td align="left" rowspan="1" colspan="1">1600 (1373,1827)</td>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">(2, 18)</td>
                          <td align="left" rowspan="1" colspan="1">Positive</td>
                          <td align="left" rowspan="1" colspan="1">52</td>
                          <td align="left" rowspan="1" colspan="1">-113(-229,2)</td>
                          <td align="left" rowspan="1" colspan="1">0.0550</td>
                          <td align="left" rowspan="1" colspan="1">-105(-209,-0.4)</td>
                          <td align="left" rowspan="1" colspan="1">0.0491</td>
                          <td align="center" rowspan="1" colspan="1">
                            <xref ref-type="table-fn" rid="t005fn004">-</xref>
                          </td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">Negative(Ref)</td>
                          <td align="left" rowspan="1" colspan="1">479</td>
                          <td align="left" rowspan="1" colspan="1">639 (601,678)</td>
                          <td align="left" rowspan="1" colspan="1">.</td>
                          <td align="left" rowspan="1" colspan="1">1005(918,1091)</td>
                          <td align="left" rowspan="1" colspan="1">.</td>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">
                            <italic>Cent/Tel1:2DS3/2DS5/2DL5<xref ref-type="table-fn" rid="t005fn003">#</xref></italic>
                          </td>
                          <td align="left" rowspan="1" colspan="1">0.08</td>
                          <td align="left" rowspan="1" colspan="1">(0, 2]</td>
                          <td align="left" rowspan="1" colspan="1">Positive</td>
                          <td align="left" rowspan="1" colspan="1">36</td>
                          <td align="left" rowspan="1" colspan="1">-406(-646,-166)</td>
                          <td align="left" rowspan="1" colspan="1">0.0009</td>
                          <td align="left" rowspan="1" colspan="1">-431(-676,-185)</td>
                          <td align="left" rowspan="1" colspan="1">0.0006</td>
                          <td align="center" rowspan="1" colspan="1">
                            <xref ref-type="table-fn" rid="t005fn006">**</xref>
                          </td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">Negative (Ref)</td>
                          <td align="left" rowspan="1" colspan="1">419</td>
                          <td align="left" rowspan="1" colspan="1">1426(1329,1523)</td>
                          <td align="left" rowspan="1" colspan="1">.</td>
                          <td align="left" rowspan="1" colspan="1">1600 (1373,1827)</td>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">(2, 18)</td>
                          <td align="left" rowspan="1" colspan="1">Positive</td>
                          <td align="left" rowspan="1" colspan="1">52</td>
                          <td align="left" rowspan="1" colspan="1">-113(-229,2)</td>
                          <td align="left" rowspan="1" colspan="1">0.0550</td>
                          <td align="left" rowspan="1" colspan="1">-105(-209,-0.4)</td>
                          <td align="left" rowspan="1" colspan="1">0.0491</td>
                          <td align="center" rowspan="1" colspan="1">
                            <xref ref-type="table-fn" rid="t005fn004">-</xref>
                          </td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">Negative (Ref)</td>
                          <td align="left" rowspan="1" colspan="1">479</td>
                          <td align="left" rowspan="1" colspan="1">639 (601,678)</td>
                          <td align="left" rowspan="1" colspan="1">.</td>
                          <td align="left" rowspan="1" colspan="1">1005(918,1091)</td>
                          <td align="left" rowspan="1" colspan="1">.</td>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"><italic>Tel1 or Tel-2DS4(2)</italic>:<italic>2DS4_AFL/3DL1</italic></td>
                          <td align="left" rowspan="1" colspan="1">0.61</td>
                          <td align="left" rowspan="1" colspan="1">All</td>
                          <td align="left" rowspan="1" colspan="1">Positive</td>
                          <td align="left" rowspan="1" colspan="1">917</td>
                          <td align="left" rowspan="1" colspan="1">250(85,414)</td>
                          <td align="left" rowspan="1" colspan="1">0.0029</td>
                          <td align="left" rowspan="1" colspan="1">232(81,383)</td>
                          <td align="left" rowspan="1" colspan="1">0.0026</td>
                          <td align="center" rowspan="1" colspan="1">
                            <xref ref-type="table-fn" rid="t005fn006">**</xref>
                          </td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">Negative(Ref)</td>
                          <td align="left" rowspan="1" colspan="1">69</td>
                          <td align="left" rowspan="1" colspan="1">749 (595,904)</td>
                          <td align="left" rowspan="1" colspan="1">.</td>
                          <td align="left" rowspan="1" colspan="1">1161(994,1327)</td>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"><italic>Tel-2DS4(4)</italic>: <italic>3DL1</italic></td>
                          <td align="left" rowspan="1" colspan="1">0.91</td>
                          <td align="left" rowspan="1" colspan="1">All</td>
                          <td align="left" rowspan="1" colspan="1">Positive</td>
                          <td align="left" rowspan="1" colspan="1">929</td>
                          <td align="left" rowspan="1" colspan="1">227(42,412)</td>
                          <td align="left" rowspan="1" colspan="1">0.0160</td>
                          <td align="left" rowspan="1" colspan="1">218(49,386)</td>
                          <td align="left" rowspan="1" colspan="1">0.0113</td>
                          <td align="center" rowspan="1" colspan="1">
                            <xref ref-type="table-fn" rid="t005fn005">*</xref>
                          </td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">Negative(Ref)</td>
                          <td align="left" rowspan="1" colspan="1">57</td>
                          <td align="left" rowspan="1" colspan="1">767 (591,944)</td>
                          <td align="left" rowspan="1" colspan="1">.</td>
                          <td align="left" rowspan="1" colspan="1">1170(985,1355)</td>
                          <td align="left" rowspan="1" colspan="1">.</td>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"><italic>Tel7 or Tel-2DS4(6)</italic>:<italic>2DS4_AFL</italic></td>
                          <td align="left" rowspan="1" colspan="1">0.19</td>
                          <td align="left" rowspan="1" colspan="1">All</td>
                          <td align="left" rowspan="1" colspan="1">Positive</td>
                          <td align="left" rowspan="1" colspan="1">950</td>
                          <td align="left" rowspan="1" colspan="1">279(112,447)</td>
                          <td align="left" rowspan="1" colspan="1">0.0011</td>
                          <td align="left" rowspan="1" colspan="1">265(103,426)</td>
                          <td align="left" rowspan="1" colspan="1">0.0013</td>
                          <td align="center" rowspan="1" colspan="1">
                            <xref ref-type="table-fn" rid="t005fn006">**</xref>
                          </td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">Negative(Ref)</td>
                          <td align="left" rowspan="1" colspan="1">36</td>
                          <td align="left" rowspan="1" colspan="1">712 (554,871)</td>
                          <td align="left" rowspan="1" colspan="1">.</td>
                          <td align="left" rowspan="1" colspan="1">1122 (952,1293)</td>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <italic>KIR/HLA</italic>
                          </td>
                          <td align="left" rowspan="1" colspan="1">
                            <italic>KIR3DL1+Bw4</italic>
                          </td>
                          <td align="left" rowspan="1" colspan="1">0.19</td>
                          <td align="left" rowspan="1" colspan="1">All</td>
                          <td align="left" rowspan="1" colspan="1">Non-3DL1+Bw4</td>
                          <td align="left" rowspan="1" colspan="1">60</td>
                          <td align="left" rowspan="1" colspan="1">-266(-413,-119)</td>
                          <td align="left" rowspan="1" colspan="1">0.0004</td>
                          <td align="left" rowspan="1" colspan="1">-190 (-331,-49)</td>
                          <td align="left" rowspan="1" colspan="1">0.0083</td>
                          <td align="center" rowspan="1" colspan="1">
                            <xref ref-type="table-fn" rid="t005fn005">*</xref>
                          </td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">Bw6/Bw6</td>
                          <td align="left" rowspan="1" colspan="1">312</td>
                          <td align="left" rowspan="1" colspan="1">-1(-113,111)</td>
                          <td align="left" rowspan="1" colspan="1">0.98</td>
                          <td align="left" rowspan="1" colspan="1">-22(-122,78)</td>
                          <td align="left" rowspan="1" colspan="1">0.67</td>
                          <td align="center" rowspan="1" colspan="1">
                            <xref ref-type="table-fn" rid="t005fn004">-</xref>
                          </td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">3DL1+Bw4(Ref)</td>
                          <td align="left" rowspan="1" colspan="1">620</td>
                          <td align="left" rowspan="1" colspan="1">995 (926,1064)</td>
                          <td align="left" rowspan="1" colspan="1">.</td>
                          <td align="left" rowspan="1" colspan="1">1389(1278,1500)</td>
                          <td align="left" rowspan="1" colspan="1">.</td>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">
                            <italic>KIR3DS1+Bw4-80I</italic>
                          </td>
                          <td align="left" rowspan="1" colspan="1">0.15</td>
                          <td align="left" rowspan="1" colspan="1">All</td>
                          <td align="left" rowspan="1" colspan="1">Non-3DS1+Bw4-80I</td>
                          <td align="left" rowspan="1" colspan="1">601</td>
                          <td align="left" rowspan="1" colspan="1">169(-2,340)</td>
                          <td align="left" rowspan="1" colspan="1">0.0531</td>
                          <td align="left" rowspan="1" colspan="1">166(9,324)</td>
                          <td align="left" rowspan="1" colspan="1">0.0386</td>
                          <td align="center" rowspan="1" colspan="1">
                            <xref ref-type="table-fn" rid="t005fn004">-</xref>
                          </td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">Bw6/Bw6</td>
                          <td align="left" rowspan="1" colspan="1">312</td>
                          <td align="left" rowspan="1" colspan="1">171(-8,351)</td>
                          <td align="left" rowspan="1" colspan="1">0.0608</td>
                          <td align="left" rowspan="1" colspan="1">141(-23,305)</td>
                          <td align="left" rowspan="1" colspan="1">0.924</td>
                          <td align="center" rowspan="1" colspan="1">
                            <xref ref-type="table-fn" rid="t005fn004">-</xref>
                          </td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">3DS1+Bw4-80I(Ref)</td>
                          <td align="left" rowspan="1" colspan="1">79</td>
                          <td align="left" rowspan="1" colspan="1">823(666,979)</td>
                          <td align="left" rowspan="1" colspan="1">.</td>
                          <td align="left" rowspan="1" colspan="1">1230(1064,1397)</td>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">
                            <italic>KIR3DL1+Bw4/Bw4-80I/Bw4-80T</italic>
                          </td>
                          <td align="left" rowspan="1" colspan="1">0.14</td>
                          <td align="left" rowspan="1" colspan="1">All</td>
                          <td align="left" rowspan="1" colspan="1">Non-3DL1+Bw4/Bw4-80I/Bw4-80T</td>
                          <td align="left" rowspan="1" colspan="1">60</td>
                          <td align="left" rowspan="1" colspan="1">-266(-413,-119)</td>
                          <td align="left" rowspan="1" colspan="1">0.0004</td>
                          <td align="left" rowspan="1" colspan="1">-190 (-331,-49)</td>
                          <td align="left" rowspan="1" colspan="1">0.0083</td>
                          <td align="center" rowspan="1" colspan="1">
                            <xref ref-type="table-fn" rid="t005fn005">*</xref>
                          </td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">Bw6/Bw6</td>
                          <td align="left" rowspan="1" colspan="1">312</td>
                          <td align="left" rowspan="1" colspan="1">-1(-113,111)</td>
                          <td align="left" rowspan="1" colspan="1">0.98</td>
                          <td align="left" rowspan="1" colspan="1">-22(-122,78)</td>
                          <td align="left" rowspan="1" colspan="1">0.67</td>
                          <td align="center" rowspan="1" colspan="1">
                            <xref ref-type="table-fn" rid="t005fn004">-</xref>
                          </td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">3DL1+Bw4/Bw4-80I/Bw4-80T(Ref)</td>
                          <td align="left" rowspan="1" colspan="1">620</td>
                          <td align="left" rowspan="1" colspan="1">995 (926,1064)</td>
                          <td align="left" rowspan="1" colspan="1">.</td>
                          <td align="left" rowspan="1" colspan="1">1389(1278,1500)</td>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">
                            <italic>Bw4/Bw6: 3DS1 <xref ref-type="table-fn" rid="t005fn003">#</xref></italic>
                          </td>
                          <td align="left" rowspan="1" colspan="1">0.054</td>
                          <td align="left" rowspan="1" colspan="1">(2,18)</td>
                          <td align="left" rowspan="1" colspan="1">Bw6/Bw6</td>
                          <td align="left" rowspan="1" colspan="1">29</td>
                          <td align="left" rowspan="1" colspan="1">269(61,477)</td>
                          <td align="left" rowspan="1" colspan="1">0.0112</td>
                          <td align="left" rowspan="1" colspan="1">209 (26,393)</td>
                          <td align="left" rowspan="1" colspan="1">0.0253</td>
                          <td align="center" rowspan="1" colspan="1">
                            <xref ref-type="table-fn" rid="t005fn004">-</xref>
                          </td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">Bw4/Bw6</td>
                          <td align="left" rowspan="1" colspan="1">63</td>
                          <td align="left" rowspan="1" colspan="1">191(45,338)</td>
                          <td align="left" rowspan="1" colspan="1">0.0105</td>
                          <td align="left" rowspan="1" colspan="1">133(0.4,266)</td>
                          <td align="left" rowspan="1" colspan="1">0.494</td>
                          <td align="center" rowspan="1" colspan="1">
                            <xref ref-type="table-fn" rid="t005fn004">-</xref>
                          </td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">Bw4/Bw4(Ref)</td>
                          <td align="left" rowspan="1" colspan="1">34</td>
                          <td align="left" rowspan="1" colspan="1">462(362,562)</td>
                          <td align="left" rowspan="1" colspan="1">.</td>
                          <td align="left" rowspan="1" colspan="1">814(655,972)</td>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                  <table-wrap-foot>
                    <fn id="t005fn001">
                      <p>*Adjusted analyses adjusted for age, study, and race</p>
                    </fn>
                    <fn id="t005fn002">
                      <p>Ref: Reference group</p>
                    </fn>
                    <fn id="t005fn003">
                      <p>#: The SNPs with a ‘#’ had genotype by age group p-value &lt;0.01.</p>
                    </fn>
                    <fn id="t005fn004">
                      <p>-: Not significant at FDR = 0.1</p>
                    </fn>
                    <fn id="t005fn005">
                      <p>*: Significant at FDR = 0.1</p>
                    </fn>
                    <fn id="t005fn006">
                      <p>**: Significant at FDR = 0.05</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
                <p>Children with <italic>KIR2DS4*AFL</italic> (<italic>Tel2DS4(6) or Tel 7</italic>), had a higher CD4<sup>+</sup> lymphocyte count compared to those without it (adjusted mean difference (β) = 265, CI (103, 426), p = 0.001, significant at an FDR = 0.05 (FDR≤0.05). A test for concordance of <italic>KIR2DS4*AFL</italic> and <italic>KIR3DL1</italic> alleles showed a strong linkage disequilibrium (kendall’s τ = 0.51, p&lt;0.001).</p>
                <p>Among the KIR centromeric and telomeric alleles the presence of <italic>KIR2DS3/2DS5/2DL1</italic> (<italic>Cent2DS3/5(1)</italic> was associated with a lower baseline CD4<sup>+</sup> lymphocyte count (β = -431, CI (-676, -185); p = 0.0006, significant at FDR = 0.05) in children ≤2 years old. <italic>KIR2DS3/2DS5/2DL5</italic> (<italic>Cent/Tel1)</italic> was in complete linkage disequilibrium with <italic>KIR2DS3/2DS5/2DL1 (Cent2DS3/5(1))</italic> and showed the same associations. Presence of <italic>KIR2DS4_ AFL /3DL1 (Tel2DS4(2) or Tel1)</italic> was associated with higher CD4<sup>+</sup> lymphocyte count (β = 232, CI (81, 383); p = 0.003, significant at FDR = 0.05) for the children of all ages.</p>
                <p>Among the combined <italic>KIR/HLA</italic> alleles, the absence of <italic>KIR3DL1</italic> and <italic>Bw4 (non-KIR3DL1+Bw4</italic>) was associated with a lower CD4<sup>+</sup> lymphocyte count compared to <italic>KIR3DL1+Bw4</italic> (β = -204, CI (-350,-59), p = 0.006; marginally significant at FDR = 0.1).</p>
              </sec>
              <sec id="sec014">
                <title>Associations of KIR and HLA alleles with baseline HIV RNA load</title>
                <p>Results of association of independent and combined KIR and HLA alleles with HIV RNA are summarized in <bold><xref rid="pone.0151364.t006" ref-type="table">Table 6</xref></bold>.</p>
                <table-wrap id="pone.0151364.t006" orientation="portrait" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0151364.t006</object-id>
                  <label>Table 6</label>
                  <caption>
                    <title>Association of <italic>KIR/HLA</italic> alleles with baseline HIV Log<sub>10</sub>RNA.</title>
                  </caption>
                  <alternatives>
                    <graphic id="pone.0151364.t006g" xlink:href="pone.0151364.t006"/>
                    <table frame="hsides" rules="groups">
                      <colgroup span="1">
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                      </colgroup>
                      <thead>
                        <tr>
                          <th align="left" colspan="6" rowspan="1">Characteristics</th>
                          <th align="left" colspan="2" rowspan="1">Unadjusted Analysis</th>
                          <th align="left" colspan="3" rowspan="1">Adjusted Analysis</th>
                        </tr>
                        <tr>
                          <th align="left" rowspan="1" colspan="1">SNP Type</th>
                          <th align="left" rowspan="1" colspan="1">SNP</th>
                          <th align="left" rowspan="1" colspan="1">Age by Genotype Interaction</th>
                          <th align="left" rowspan="1" colspan="1">Age Group</th>
                          <th align="left" rowspan="1" colspan="1">Level</th>
                          <th align="left" rowspan="1" colspan="1">Count</th>
                          <th align="left" rowspan="1" colspan="1">Difference (LCI, UCI)</th>
                          <th align="left" rowspan="1" colspan="1">P-value</th>
                          <th align="left" rowspan="1" colspan="1">Difference (LCI, UCI)</th>
                          <th align="left" rowspan="1" colspan="1">P-value</th>
                          <th align="left" rowspan="1" colspan="1">Significant Controlling for FDR at 0.1</th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <italic>KIR</italic>
                          </td>
                          <td align="left" rowspan="1" colspan="1">
                            <italic>KIR 2DS2</italic>
                            <xref ref-type="table-fn" rid="t006fn003">#</xref>
                          </td>
                          <td align="left" rowspan="1" colspan="1">0.0190</td>
                          <td align="left" rowspan="1" colspan="1">(0, 2]</td>
                          <td align="left" rowspan="1" colspan="1">Positive</td>
                          <td align="left" rowspan="1" colspan="1">189</td>
                          <td align="left" rowspan="1" colspan="1">0.2(0.0,0.4)</td>
                          <td align="left" rowspan="1" colspan="1">0.0290</td>
                          <td align="left" rowspan="1" colspan="1">0.2(0.0,0.3)</td>
                          <td align="left" rowspan="1" colspan="1">0.0354</td>
                          <td align="left" rowspan="1" colspan="1">
                            <xref ref-type="table-fn" rid="t006fn004">-</xref>
                          </td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">Negative (Ref)</td>
                          <td align="left" rowspan="1" colspan="1">193</td>
                          <td align="left" rowspan="1" colspan="1">5.5(5.4,5.6)</td>
                          <td align="left" rowspan="1" colspan="1">.</td>
                          <td align="left" rowspan="1" colspan="1">6.2(6.0,6.4)</td>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">
                            <italic>KIR 2DS4_AFL</italic>
                            <xref ref-type="table-fn" rid="t006fn003">#</xref>
                            <italic>(Tel 7 orTel-2DS4_6</italic>
                          </td>
                          <td align="left" rowspan="1" colspan="1">0.0447</td>
                          <td align="left" rowspan="1" colspan="1">(0, 2]</td>
                          <td align="left" rowspan="1" colspan="1">Positive</td>
                          <td align="left" rowspan="1" colspan="1">372</td>
                          <td align="left" rowspan="1" colspan="1">-0.7(-1.2,-0.3)</td>
                          <td align="left" rowspan="1" colspan="1">0.0016</td>
                          <td align="left" rowspan="1" colspan="1">-0.6(-1.0,-0.2)</td>
                          <td align="left" rowspan="1" colspan="1">0.0055</td>
                          <td align="left" rowspan="1" colspan="1">
                            <xref ref-type="table-fn" rid="t006fn005">*</xref>
                          </td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">Negative (Ref)</td>
                          <td align="left" rowspan="1" colspan="1">10</td>
                          <td align="left" rowspan="1" colspan="1">6.3(5.9,6.8)</td>
                          <td align="left" rowspan="1" colspan="1">.</td>
                          <td align="left" rowspan="1" colspan="1">6.9(6.5,7.3)</td>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"><italic>KIR</italic> centromeric/ telomeric</td>
                          <td align="left" rowspan="1" colspan="1"><italic>Cent2</italic>:<italic>2DL1/2DL3/2DL2/2DS2</italic><xref ref-type="table-fn" rid="t006fn003">#</xref></td>
                          <td align="left" rowspan="1" colspan="1">0.0043</td>
                          <td align="left" rowspan="1" colspan="1">(0, 2]</td>
                          <td align="left" rowspan="1" colspan="1">Positive</td>
                          <td align="left" rowspan="1" colspan="1">117</td>
                          <td align="left" rowspan="1" colspan="1">0.3(0.1,0.5)</td>
                          <td align="left" rowspan="1" colspan="1">0.0024</td>
                          <td align="left" rowspan="1" colspan="1">0.2(0.1,0.4)</td>
                          <td align="left" rowspan="1" colspan="1">0.0063</td>
                          <td align="left" rowspan="1" colspan="1">
                            <xref ref-type="table-fn" rid="t006fn005">*</xref>
                          </td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">Negative (Ref)</td>
                          <td align="left" rowspan="1" colspan="1">265</td>
                          <td align="left" rowspan="1" colspan="1">5.5(5.4,5.6)</td>
                          <td align="left" rowspan="1" colspan="1">.</td>
                          <td align="left" rowspan="1" colspan="1">6.3(6.1,6.5)</td>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"><italic>Cent3</italic>: <italic>2DL1/2DL3/2DL2</italic><xref ref-type="table-fn" rid="t006fn003">#</xref></td>
                          <td align="left" rowspan="1" colspan="1">0.0128</td>
                          <td align="left" rowspan="1" colspan="1">(0, 2]</td>
                          <td align="left" rowspan="1" colspan="1">Positive</td>
                          <td align="left" rowspan="1" colspan="1">127</td>
                          <td align="left" rowspan="1" colspan="1">0.2(0.1,0.4)</td>
                          <td align="left" rowspan="1" colspan="1">0.0090</td>
                          <td align="left" rowspan="1" colspan="1">0.2(0.0,0.4)</td>
                          <td align="left" rowspan="1" colspan="1">0.0118</td>
                          <td align="left" rowspan="1" colspan="1">
                            <xref ref-type="table-fn" rid="t006fn004">-</xref>
                          </td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">Negative (Ref)</td>
                          <td align="left" rowspan="1" colspan="1">255</td>
                          <td align="left" rowspan="1" colspan="1">5.5(5.4,5.6)</td>
                          <td align="left" rowspan="1" colspan="1">.</td>
                          <td align="left" rowspan="1" colspan="1">6.3(6.1,6.5)</td>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"><italic>Cent4</italic>: <italic>2DL1/2DL3/2DS2</italic><xref ref-type="table-fn" rid="t006fn003">#</xref></td>
                          <td align="left" rowspan="1" colspan="1">0.0033</td>
                          <td align="left" rowspan="1" colspan="1">(0, 2]</td>
                          <td align="left" rowspan="1" colspan="1">Positive</td>
                          <td align="left" rowspan="1" colspan="1">120</td>
                          <td align="left" rowspan="1" colspan="1">0.3(0.1,0.4)</td>
                          <td align="left" rowspan="1" colspan="1">0.0030</td>
                          <td align="left" rowspan="1" colspan="1">0.2(0.1,0.4)</td>
                          <td align="left" rowspan="1" colspan="1">0.0051</td>
                          <td align="left" rowspan="1" colspan="1">
                            <xref ref-type="table-fn" rid="t006fn005">*</xref>
                          </td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">Negative (Ref)</td>
                          <td align="left" rowspan="1" colspan="1">262</td>
                          <td align="left" rowspan="1" colspan="1">5.5(5.4,5.6)</td>
                          <td align="left" rowspan="1" colspan="1">.</td>
                          <td align="left" rowspan="1" colspan="1">6.3(6.1,6.5)</td>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"><italic>Cent6</italic>: <italic>2DL1/2DL2/2DS2</italic><xref ref-type="table-fn" rid="t006fn003">#</xref></td>
                          <td align="left" rowspan="1" colspan="1">0.0373</td>
                          <td align="left" rowspan="1" colspan="1">(0, 2]</td>
                          <td align="left" rowspan="1" colspan="1">Positive</td>
                          <td align="left" rowspan="1" colspan="1">179</td>
                          <td align="left" rowspan="1" colspan="1">0.2(0.0,0.4)</td>
                          <td align="left" rowspan="1" colspan="1">0.0274</td>
                          <td align="left" rowspan="1" colspan="1">0.2(0.0,0.3)</td>
                          <td align="left" rowspan="1" colspan="1">0.0319</td>
                          <td align="left" rowspan="1" colspan="1">
                            <xref ref-type="table-fn" rid="t006fn004">-</xref>
                          </td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">Negative (Ref)</td>
                          <td align="left" rowspan="1" colspan="1">203</td>
                          <td align="left" rowspan="1" colspan="1">5.5(5.4,5.6)</td>
                          <td align="left" rowspan="1" colspan="1">.</td>
                          <td align="left" rowspan="1" colspan="1">6.2(6.0,6.4)</td>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"><italic>Cent7</italic>: <italic>2DL2/2DS2</italic><xref ref-type="table-fn" rid="t006fn003">#</xref></td>
                          <td align="left" rowspan="1" colspan="1">0.0255</td>
                          <td align="left" rowspan="1" colspan="1">(0, 2]</td>
                          <td align="left" rowspan="1" colspan="1">Positive</td>
                          <td align="left" rowspan="1" colspan="1">186</td>
                          <td align="left" rowspan="1" colspan="1">0.2(0.0,0.4)</td>
                          <td align="left" rowspan="1" colspan="1">0.0255</td>
                          <td align="left" rowspan="1" colspan="1">0.2(0.0,0.3)</td>
                          <td align="left" rowspan="1" colspan="1">0.0410</td>
                          <td align="left" rowspan="1" colspan="1">
                            <xref ref-type="table-fn" rid="t006fn004">-</xref>
                          </td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">Negative (Ref)</td>
                          <td align="left" rowspan="1" colspan="1">196</td>
                          <td align="left" rowspan="1" colspan="1">5.5(5.4,5.6)</td>
                          <td align="left" rowspan="1" colspan="1">.</td>
                          <td align="left" rowspan="1" colspan="1">6.2(6.0,6.4)</td>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"><italic>Cent8</italic>: <italic>2DL2/2DL3/2DS2</italic><xref ref-type="table-fn" rid="t006fn003">#</xref></td>
                          <td align="left" rowspan="1" colspan="1">0.0043</td>
                          <td align="left" rowspan="1" colspan="1">(0, 2]</td>
                          <td align="left" rowspan="1" colspan="1">Positive</td>
                          <td align="left" rowspan="1" colspan="1">117</td>
                          <td align="left" rowspan="1" colspan="1">0.3(0.1,0.5)</td>
                          <td align="left" rowspan="1" colspan="1">0.0024</td>
                          <td align="left" rowspan="1" colspan="1">0.2(0.1,0.4)</td>
                          <td align="left" rowspan="1" colspan="1">0.0063</td>
                          <td align="left" rowspan="1" colspan="1">
                            <xref ref-type="table-fn" rid="t006fn005">*</xref>
                          </td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">Negative (Ref)</td>
                          <td align="left" rowspan="1" colspan="1">265</td>
                          <td align="left" rowspan="1" colspan="1">5.5(5.4,5.6)</td>
                          <td align="left" rowspan="1" colspan="1">.</td>
                          <td align="left" rowspan="1" colspan="1">6.3(6.1,6.5)</td>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <italic>KIR/HLA</italic>
                          </td>
                          <td align="left" rowspan="1" colspan="1">
                            <italic>KIR3DS1+Bw4-80I</italic>
                            <xref ref-type="table-fn" rid="t006fn003">#</xref>
                          </td>
                          <td align="left" rowspan="1" colspan="1">0.0790</td>
                          <td align="left" rowspan="1" colspan="1">(2, 18)</td>
                          <td align="left" rowspan="1" colspan="1">Non-3DS1+Bw4-80I</td>
                          <td align="left" rowspan="1" colspan="1">267</td>
                          <td align="left" rowspan="1" colspan="1">-0.4(-0.6,-0.1)</td>
                          <td align="left" rowspan="1" colspan="1">0.0015</td>
                          <td align="left" rowspan="1" colspan="1">-0.4(-0.6,-0.1)</td>
                          <td align="left" rowspan="1" colspan="1">0.0008</td>
                          <td align="left" rowspan="1" colspan="1">
                            <xref ref-type="table-fn" rid="t006fn005">*</xref>
                          </td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">Bw6/Bw6</td>
                          <td align="left" rowspan="1" colspan="1">143</td>
                          <td align="left" rowspan="1" colspan="1">-0.4(-0.6,-0.1)</td>
                          <td align="left" rowspan="1" colspan="1">0.0029</td>
                          <td align="left" rowspan="1" colspan="1">-0.4(-0.6,-0.2)</td>
                          <td align="left" rowspan="1" colspan="1">0.0019</td>
                          <td align="left" rowspan="1" colspan="1">
                            <xref ref-type="table-fn" rid="t006fn005">*</xref>
                          </td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1">3DS1+Bw4-80I(Ref)</td>
                          <td align="left" rowspan="1" colspan="1">38</td>
                          <td align="left" rowspan="1" colspan="1">5.0(4.8,5.2)</td>
                          <td align="left" rowspan="1" colspan="1">.</td>
                          <td align="left" rowspan="1" colspan="1">4.8(4.6,5.1)</td>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                  <table-wrap-foot>
                    <fn id="t006fn001">
                      <p>Adjusted analyses adjusted for age, study, and race</p>
                    </fn>
                    <fn id="t006fn002">
                      <p>Ref: Reference group</p>
                    </fn>
                    <fn id="t006fn003">
                      <p>#: The SNPs with a ‘#’ had genotype by age group p-value &lt;0.01.</p>
                    </fn>
                    <fn id="t006fn004">
                      <p>-: Not significant at FDR = 0.1</p>
                    </fn>
                    <fn id="t006fn005">
                      <p>*: Significant at FDR = 0.1</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
                <p>In children ≤2 years old, the presence of KIR-2DS4* AFL, (<italic>Tel2DS4(6)</italic> or Tel7) was associated with lower log<sub>10</sub> viral RNA load compared to those without it (β = -0.6, CI (-1.0, -0.2), p = 0.006; significant at FDR &lt;0.05) which is in agreement with the higher CD4<sup>+</sup> lymphocyte count observed above. This decrease in HIV RNA was not significant in the older age cohort, &gt; 2 years old (FDR &gt;0.1).</p>
                <p>Among the <italic>KIR</italic> centromeric and telomeric alleles, the presence of <italic>KIR2DL1/2DL3/2DL2/2DS2 (Cent2</italic> or <italic>Cent8)</italic> was associated with higher HIV RNA load (β = 0.2, CI (0.1, 0.4); p = 0.006, marginally significant at FDR = 0.1) in children ≤ 2 years old. The presence of <italic>KIR2DL1/2DL3/2DS2 (Cent4</italic>) was associated with higher HIV RNA load (β = 0.2, CI (0.1, 0.4); p = 0.005, marginally significant at FDR = 0.1) in ≤ 2 year old children.</p>
                <p>Among the combined <italic>KIR/HLA alleles</italic>, the absence of <italic>KIR3DS1</italic> and <italic>Bw4-80I (non-KIR3DS1+Bw4-80I)</italic> was associated with lower HIV RNA load compared to <italic>3DS1+Bw4-80I</italic> (β = -0.4, CI (-0.6,-0.1), p = 0.0014, significant at FDR &lt;0.05). Also, the presence of <italic>Bw6/Bw6</italic> was associated with lower viral load compared to <italic>3DS1+Bw4-80I</italic> (β = 0.4, CI (-0.6,-0.2); p = 0.0009, significant at FDR &lt;0.05). These estimated differences remained significant after the FDR adjustment.</p>
                <p>No statistically significant associations were observed for any of the combined <italic>KIR/HLA</italic> alleles on the baseline cognitive score. Furthermore, no combination of <italic>HLA-C1</italic> or <italic>C2</italic> alleles with <italic>KIR</italic> alleles were significantly associated with the baseline CD4 count, logRNA viral load or cognitive score.</p>
              </sec>
            </sec>
            <sec sec-type="conclusions" id="sec015">
              <title>Discussion</title>
              <p>Natural killer cells modulate antiviral immune response [<xref rid="pone.0151364.ref038" ref-type="bibr">38</xref>] by mediating the KIR mediated lysis of the targeted infected cells [<xref rid="pone.0151364.ref010" ref-type="bibr">10</xref>–<xref rid="pone.0151364.ref017" ref-type="bibr">17</xref>]. Through the release of various cytokines, a strong adaptive immune response is activated that leads to T cell proliferation and a reduction in viral replication [<xref rid="pone.0151364.ref039" ref-type="bibr">39</xref>]. Functions of NK cells are regulated by the activating or inhibiting KIRs and their HLA class I ligands [<xref rid="pone.0151364.ref004" ref-type="bibr">4</xref>]. Thus, the presence of <italic>KIR</italic> alleles coding specific NK receptors and <italic>HLA</italic> Class I ligand alleles for NK cell function can alter the anti-HIV innate immune response in infected children. In the research presented, we tested the association of the specific KIR alleles independently or in combination with ligand <italic>HLA</italic> class I alleles with the HIV-related disease status markers in children.</p>
              <p>First, we estimated the effects of independent <italic>KIR</italic> alleles on HIV disease. We found that the presence of the NK cell activating allele, <italic>KIR2DS4*AFL</italic> was associated with a higher CD4<sup>+</sup> lymphocyte count and lower viral RNA loads in children ≤2 years old, as well as an increase in baseline cognitive score. <italic>KIR2DS4</italic> is an activating gene for NK function. Hence, the presence of <italic>KIR2DS4</italic> is expected to be associated with a functional NK response and protective effects against HIV infection and disease. Contrary to our findings, a study conducted in antiretroviral naïve adults has recently shown that <italic>KIR2DS4</italic> promotes HIV pathogenesis [<xref rid="pone.0151364.ref040" ref-type="bibr">40</xref>]. Reasons for the difference in our findings are unclear. It is possible that in adults, the adaptive immune response via HLA-HIV peptide-CD8 interactions predominates over the <italic>KIR</italic> mediated innate immune response observed in children.</p>
              <p>The presence of inhibiting allele <italic>KIR2DL2*004</italic> was associated with lower CD4<sup>+</sup> counts compared to those without it. This effect of <italic>KIR2DL2</italic> has been reported in adults where the presence of <italic>KIR2DL2</italic> was also shown to be associated with a more rapid rate of CD4<sup>+</sup> lymphocyte decline due to inhibition of NK cell function [<xref rid="pone.0151364.ref017" ref-type="bibr">17</xref>].</p>
              <p>Similar to <italic>KIR2DL2 allele</italic>, the presence of the <italic>KIR2DS2</italic> allele has been shown to be associated with a more rapid rate of CD4<sup>+</sup> T lymphocyte decline [<xref rid="pone.0151364.ref017" ref-type="bibr">17</xref>]. Consistent with these findings, our study showed that the presence of <italic>KIR2DS2</italic> allele was associated with higher plasma HIV RNA in children ≤2 years old.</p>
              <p>A unique aspect of our study was the evaluation of the association of <italic>KIR</italic> alleles with HIV-related central nervous system (CNS) impairment. Of note, although a few <italic>KIR</italic> alleles had a p-value &lt;0.05 for the cognitive score analyses, none retained significance after controlling for FDR. In a simian immunodeficiency virus (SIV) model of encephalitis in macaques, animals lacking strong NK cell responses developed more severe CNS lesions than those with robust responses [<xref rid="pone.0151364.ref041" ref-type="bibr">41</xref>]. <italic>In vivo</italic>, both macaque and human cells showed that NK cells mediated anti-SIV and anti-HIV cytolytic effects directed against the envelope protein. Hence, NK cells recognize and lyse cells expressing SIV and HIV antigens suggesting that NK cells affect HIV related CNS disease [<xref rid="pone.0151364.ref041" ref-type="bibr">41</xref>]. Thus, activating and inhibiting <italic>KIR</italic> alleles can modulate these CNS effects against HIV as observed in our studies.</p>
              <p>Second, we investigated the effects of <italic>KIR</italic> centromeric and telomeric alleles on the HIV related disease in children. Among these, the presence of centromeric allele <italic>2DS3/2DS5/2DL1 [Cent2DS3/5(1)]</italic>, <italic>2DL1/2DL3/2DL2 (Cent3)</italic>, <italic>2DL1/2DL3/2DS2 (Cent4) or 2DL2/2DL3/2DS2 (Cent8)</italic> was associated with higher HIV RNA load in children ≤ 2 years old probably because of the predominant presence of inhibiting KIR molecules that inhibited NK cell function. Among the <italic>KIR</italic> telomeric alleles, the presence of <italic>2DS4_AFL/3DL1 [Tel-2DS4(2)] or 2DS4AFL/3DL1 (Tel1))</italic>, <italic>3DL1 [Tel2DS4(4) or Tel8]</italic> and <italic>2DS4AFL [Tel2DS4(6) or Tel 7]</italic> was associated with higher CD4<sup>+</sup> lymphocytes count and lower viral RNA load in the whole cohort because of the preponderance of stimulating KIR molecules that activated NK cells for killing of HIV infected cells. Significant age and genotype interactions observed in our study may suggest an age dependent maturation of the adaptive immune response reflected in <italic>KIR/HLA</italic> mediated NK cell response.</p>
              <p>Finally, we tested the presence of combined <italic>KIR</italic> and <italic>HLA</italic> alleles on HIV disease in children. <italic>KIR</italic> and <italic>HLA</italic> class I alleles have been shown to act both independently and synergistically to modify HIV disease progression in adults [<xref rid="pone.0151364.ref017" ref-type="bibr">17</xref>]. <italic>HLA-Bw4</italic> molecules with isoleucine at position 80 (<italic>Bw4-80I</italic>) are ligands for inhibitory <italic>KIR3DL1</italic> receptors and <italic>Bw4-80Ile</italic>. Combined with the activating <italic>KIR3DS1</italic> allele, these have been found to be associated with delayed progression to AIDS [<xref rid="pone.0151364.ref011" ref-type="bibr">11</xref>]. In our study, the absence of <italic>KIR3DL1</italic> and <italic>Bw4</italic> (non-<italic>KIR3DL1+Bw4</italic>) was associated with a lower CD4<sup>+</sup> lymphocyte count. These results are in concordance with those in adults where the presence of <italic>KIR3DL1</italic> and <italic>Bw4</italic> was associated with slower HIV disease progression [<xref rid="pone.0151364.ref006" ref-type="bibr">6</xref>]. NK cells kill their HIV-infected target cells in a receptor ligand-specific manner that involved activating KIR3DS1 and its putative ligand HLA-Bw4-80I [<xref rid="pone.0151364.ref042" ref-type="bibr">42</xref>]. However, in the current study, different to other studies in adults [<xref rid="pone.0151364.ref010" ref-type="bibr">10</xref>], the absence of <italic>KIR3DS1+Bw4-80I</italic> was associated with lower HIV RNA load compared to those with <italic>Bw6/Bw6</italic> group. Reasons for these differences are not clear but may reflect a different NK cell mediated innate immune response in children compared to adults. This may also be explained by the unique nature of our cohort (approximately 61% African-American), wherein the frequencies and protective effects of HLA-B alleles on HIV disease progression differs from Caucasian cohorts.</p>
              <p>In an earlier study in adults, the frequency of the <italic>KIR3DS1 (3DS1/3DL1)-Bw4</italic> combination was significantly higher in highly exposed and persistently seronegative patients versus discordant couples [<xref rid="pone.0151364.ref006" ref-type="bibr">6</xref>;<xref rid="pone.0151364.ref012" ref-type="bibr">12</xref>]. Higher frequency of <italic>KIR3DS1/3DL1</italic> heterozygotes and HLA-<italic>Bw4-80I</italic> has been associated with long-term non-progressors [<xref rid="pone.0151364.ref010" ref-type="bibr">10</xref>]. Consistent with these findings, our study showed that the presence of <italic>KIR3DS1</italic> and <italic>Bw4-80I</italic> was associated with higher CD4<sup>+</sup> lymphocyte counts and lower HIV RNA.</p>
              <p>Due to the presence of different <italic>KIR</italic> and <italic>HLA</italic> alleles, the varied expression of KIRs on different NK cells and CD8<sup>+</sup> T lymphocytes potentially generate selective antiviral responses. For example, <italic>HLA-B</italic> alleles encode a peptide epitope sequence that controls allele-specific interactions with the inhibitory <italic>KIR3DL1</italic> allele. HIV infected cells that may avoid immunosurveillance by downregulating the HLA-B expression, are killed by NK cells upon the loss of inhibitory NK receptor signals such as <italic>KIR3DL1</italic>. Thus, NK receptors directly participate in the adaptive immune response due to the expression of KIRs on CD8<sup>+</sup> T cells [<xref rid="pone.0151364.ref043" ref-type="bibr">43</xref>;<xref rid="pone.0151364.ref044" ref-type="bibr">44</xref>].</p>
              <p>An association of <italic>KIR/HLA</italic> alleles has been reported with the risk for HIV mother-to-child-transmission in two studies [<xref rid="pone.0151364.ref045" ref-type="bibr">45</xref>;<xref rid="pone.0151364.ref046" ref-type="bibr">46</xref>]. In these studies, the presence of <italic>KIR2DS4</italic> allelic variants had differential effects on <italic>in utero</italic> and intrapartum transmission. Additionally, a strong association has been observed with maternal <italic>HLA-B</italic> alleles independent of viral load. This finding implicates innate immune mechanisms via NK receptor KIR3DL1 that are triggered by a decrease in the expression of <italic>HLA</italic> class I molecules [<xref rid="pone.0151364.ref047" ref-type="bibr">47</xref>]. A decreased <italic>HLA</italic>-<italic>B</italic> expression on infected cells removes the inhibitory signal by <italic>KIR3DL1</italic> and lowers the threshold for CD8<sup>+</sup> T-cell activation by viral peptides enhancing the adaptive CD8<sup>+</sup> T-cell anti-HIV response. Furthermore, a blockade of NK cell inhibiting KIR molecules can also improve the anti-HIV-1 activity of NK cells [<xref rid="pone.0151364.ref048" ref-type="bibr">48</xref>].</p>
              <p>The presence of <italic>HLA-C1</italic> or <italic>C2</italic> alleles in combination with <italic>KIR2DL</italic> or <italic>KIR2DS</italic> alleles has been reported to be associated with HIV disease [<xref rid="pone.0151364.ref049" ref-type="bibr">49</xref>;<xref rid="pone.0151364.ref050" ref-type="bibr">50</xref>]; however we did not observe it in the children cohort. Reasons for these results are not clear but as noted above, these may reflect a difference in the maturity of NK cell mediated innate immune response in children compared to adults and the unique nature of our predominant African-American cohort.</p>
              <p>In summary, our study has shown that <italic>KIR</italic> alleles are associated with altered HIV disease pathogenesis in children independently and in combination with <italic>HLA</italic> class I ligands. In general, effects of <italic>KIR</italic> alleles on HIV disease in children follow the pattern observed in adults. Additionally, there was an age dependent association of <italic>KIR</italic> alleles with HIV disease observed particularly in younger children suggesting an effect of maturation of innate and adaptive immune responses. These studies will help guide the development of <italic>KIR/HLA</italic> based therapeutic targets against HIV disease.</p>
            </sec>
          </body>
          <back>
            <ack>
              <p>The authors acknowledge and thank the P152/P300 participants and their families as well as site personnel for their contributions to the studies. The authors also acknowledge the Pediatric AIDS Clinical Trials Group (PACTG) for the support. This research was supported in part by 1R01NS077874 (SAS), UM1AI068616 (MQ, SSB, TF), the International Maternal Perinatal Adolescent AIDS Clinical Trials (IMPAACT) Network. Overall support for the International Maternal Pediatric Adolescent AIDS Clinical Trials Group (IMPAACT) was provided by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) under Award Numbers UM1AI068632 (IMPAACT LOC), UM1AI068616 (IMPAACT SDMC) and UM1AI106716 (IMPAACT LC), with co-funding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the National Institute of Mental Health (NIMH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.</p>
            </ack>
            <ref-list>
              <title>References</title>
              <ref id="pone.0151364.ref001">
                <label>1</label>
                <mixed-citation publication-type="journal"><name><surname>Vivier</surname><given-names>E</given-names></name>, <name><surname>Raulet</surname><given-names>DH</given-names></name>, <name><surname>Moretta</surname><given-names>A</given-names></name>, <name><surname>Caligiuri</surname><given-names>MA</given-names></name>, <name><surname>Zitvogel</surname><given-names>L</given-names></name>, <name><surname>Lanier</surname><given-names>LL</given-names></name>, <etal>et al</etal><article-title>Innate or Adaptive Immunity? The Example of Natural Killer Cells</article-title>. <source>Science</source>. <year>2011</year>;<volume>331</volume>: <fpage>44</fpage>–<lpage>49</lpage>. <pub-id pub-id-type="doi">10.1126/science.1198687</pub-id>
<?supplied-pmid 21212348?><pub-id pub-id-type="pmid">21212348</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0151364.ref002">
                <label>2</label>
                <mixed-citation publication-type="journal"><name><surname>Trichieri</surname><given-names>G</given-names></name>. <article-title>Biology of natural killer cells</article-title>. <source>Adv Immunol</source>. <year>1989</year>;<volume>47</volume>: <fpage>87</fpage>–<lpage>376</lpage>.</mixed-citation>
              </ref>
              <ref id="pone.0151364.ref003">
                <label>3</label>
                <mixed-citation publication-type="journal"><name><surname>Moretta</surname><given-names>A</given-names></name>, <name><surname>Bottino</surname><given-names>C</given-names></name>, <name><surname>Vitale</surname><given-names>M</given-names></name>, <name><surname>Pende</surname><given-names>D</given-names></name>, <name><surname>Biassoni</surname><given-names>R</given-names></name>, <name><surname>Mingari</surname><given-names>MC</given-names></name>, <etal>et al</etal><article-title>Receptors for HLA-class I molecules in human natural killer cells</article-title>. <source>Annu Rev Immunol</source>. <year>1996</year>;<volume>14</volume>: <fpage>619</fpage>–<lpage>648</lpage>. <?supplied-pmid 8717527?><pub-id pub-id-type="pmid">8717527</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0151364.ref004">
                <label>4</label>
                <mixed-citation publication-type="journal"><name><surname>Carrington</surname><given-names>M</given-names></name>, <name><surname>Martin</surname><given-names>MP</given-names></name>, <name><surname>Bergen</surname><given-names>JV</given-names></name>. <article-title><italic>KIR-HLA</italic> intercourse in HIV disease</article-title>. <source>Trends Microbiol</source>. <year>2008</year>;<volume>16</volume>: <fpage>620</fpage>–<lpage>627</lpage>. <pub-id pub-id-type="doi">10.1016/j.tim.2008.09.002</pub-id>
<?supplied-pmid 18976921?><pub-id pub-id-type="pmid">18976921</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0151364.ref005">
                <label>5</label>
                <mixed-citation publication-type="journal"><name><surname>Moretta</surname><given-names>A</given-names></name>, <name><surname>Biassoni</surname><given-names>R</given-names></name>, <name><surname>Bottino</surname><given-names>C</given-names></name>, <name><surname>Pende</surname><given-names>D</given-names></name>, <name><surname>Vitale</surname><given-names>M</given-names></name>, <name><surname>Poggi</surname><given-names>A</given-names></name>, <etal>et al</etal><article-title>Major histocompatibility complex class-I specific receptors on human natural killer and T lymphocytes</article-title>. <source>Immunol Rev</source>. <year>1997</year>;<volume>155</volume>: <fpage>105</fpage>–<lpage>117</lpage>. <?supplied-pmid 9059886?><pub-id pub-id-type="pmid">9059886</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0151364.ref006">
                <label>6</label>
                <mixed-citation publication-type="journal"><name><surname>Martin</surname><given-names>MP</given-names></name>, <name><surname>Qi</surname><given-names>Y</given-names></name>, <name><surname>Gao</surname><given-names>X</given-names></name>, <name><surname>Yamada</surname><given-names>E</given-names></name>, <name><surname>Martin</surname><given-names>JN</given-names></name>, <name><surname>Pereyra</surname><given-names>F</given-names></name>, <etal>et al</etal><article-title>Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1</article-title>. <source>Nat Genet</source>. <year>2007</year>;<volume>39</volume>: <fpage>733</fpage>–<lpage>740</lpage>. <?supplied-pmid 17496894?><pub-id pub-id-type="pmid">17496894</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0151364.ref007">
                <label>7</label>
                <mixed-citation publication-type="journal"><name><surname>Bashirova</surname><given-names>AA</given-names></name>, <name><surname>Thomas</surname><given-names>R</given-names></name>, <name><surname>Carrington</surname><given-names>M</given-names></name>. <article-title>HLA/KIR restraint of HIV: surviving the fittest</article-title>. <source>Annu Rev Immunol</source>. <year>2011</year>;<volume>29</volume>: <fpage>295</fpage>–<lpage>317</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-immunol-031210-101332</pub-id>
<?supplied-pmid 21219175?><pub-id pub-id-type="pmid">21219175</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0151364.ref008">
                <label>8</label>
                <mixed-citation publication-type="journal"><name><surname>Martin</surname><given-names>MP</given-names></name>, <name><surname>Carrington</surname><given-names>M</given-names></name>. <article-title>Immunogenetics of HIV disease</article-title>. <source>Immunol Rev</source>. <year>2013</year>;<volume>254</volume>: <fpage>245</fpage>–<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1111/imr.12071</pub-id>
<?supplied-pmid 23772624?><pub-id pub-id-type="pmid">23772624</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0151364.ref009">
                <label>9</label>
                <mixed-citation publication-type="journal"><name><surname>Paximadis</surname><given-names>M</given-names></name>, <name><surname>Minevich</surname><given-names>G</given-names></name>, <name><surname>Winchester</surname><given-names>R</given-names></name>, <name><surname>Schramm</surname><given-names>DB</given-names></name>, <name><surname>Gray</surname><given-names>GE</given-names></name>, <name><surname>Sherman</surname><given-names>GG</given-names></name>, <etal>et al</etal><article-title>KIR-HLA and maternal-infant HIV-1 transmission in sub-Saharan Africa</article-title>. <source>PLoS One</source>. <year>2011</year>;<volume>6</volume>: <fpage>e16541</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0016541</pub-id><?supplied-pmid 21346814?><pub-id pub-id-type="pmid">21346814</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0151364.ref010">
                <label>10</label>
                <mixed-citation publication-type="journal"><name><surname>Jiang</surname><given-names>Y</given-names></name>, <name><surname>Chen</surname><given-names>O</given-names></name>, <name><surname>Cui</surname><given-names>C</given-names></name>, <name><surname>Zhao</surname><given-names>B</given-names></name>, <name><surname>Han</surname><given-names>X</given-names></name>, <name><surname>Zhang</surname><given-names>Z</given-names></name>, <etal>et al</etal><article-title>KIR3DS1/L1 and HLA-Bw4-80I are associated with HIV disease progression among HIV typical progressors and long-term nonprogressors</article-title>. <source>BMC Infect Dis</source>. <year>2013</year>;<volume>13</volume>: <fpage>405</fpage><pub-id pub-id-type="doi">10.1186/1471-2334-13-405</pub-id><?supplied-pmid 24059286?><pub-id pub-id-type="pmid">24059286</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0151364.ref011">
                <label>11</label>
                <mixed-citation publication-type="journal"><name><surname>Martin</surname><given-names>MP</given-names></name>, <name><surname>Gao</surname><given-names>X</given-names></name>, <name><surname>Lee</surname><given-names>JH</given-names></name>, <name><surname>Nelson</surname><given-names>GW</given-names></name>, <name><surname>Detels</surname><given-names>R</given-names></name>, <name><surname>Goedert</surname><given-names>JJ</given-names></name>, <etal>et al</etal><article-title>Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS</article-title>. <source>Nat Genet</source>. <year>2002</year>;<volume>31</volume>: <fpage>429</fpage>–<lpage>434</lpage>. <?supplied-pmid 12134147?><pub-id pub-id-type="pmid">12134147</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0151364.ref012">
                <label>12</label>
                <mixed-citation publication-type="journal"><name><surname>Habegger de Sorrentino</surname><given-names>A</given-names></name>, <name><surname>Sinchi</surname><given-names>JL</given-names></name>, <name><surname>Marinic</surname><given-names>K</given-names></name>, <name><surname>López</surname><given-names>R</given-names></name>, <name><surname>Iliovich</surname><given-names>E</given-names></name>. <article-title>KIR-HLA-A and B alleles of the Bw4 epitope against HIV infection in discordant heterosexual couples in Chaco Argentina</article-title>. <source>Immunology</source>. <year>2013</year>;<volume>140</volume>: <fpage>273</fpage>–<lpage>279</lpage>. <pub-id pub-id-type="doi">10.1111/imm.12137</pub-id>
<?supplied-pmid 23789883?><pub-id pub-id-type="pmid">23789883</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0151364.ref013">
                <label>13</label>
                <mixed-citation publication-type="journal"><name><surname>López-Vázquez</surname><given-names>A</given-names></name>, <name><surname>Miña-Blanco</surname><given-names>A</given-names></name>, <name><surname>Martínez-Borra</surname><given-names>J</given-names></name>, <name><surname>Njobvu</surname><given-names>PD</given-names></name>, <name><surname>Suárez-Alvarez</surname><given-names>B</given-names></name>, <name><surname>Blanco-Gelaz</surname><given-names>MA</given-names></name>, <etal>et al</etal><article-title>Interaction between KIR3DL1 and HLA-B*57 supertype alleles influences the progression of HIV-1 infection in a Zambian population</article-title>. <source>Hum Immunol</source>. <year>2005</year>;<volume>66</volume>: <fpage>285</fpage>–<lpage>289</lpage>. <?supplied-pmid 15784466?><pub-id pub-id-type="pmid">15784466</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0151364.ref014">
                <label>14</label>
                <mixed-citation publication-type="journal"><name><surname>Tiemessen</surname><given-names>CT</given-names></name>, <name><surname>Paximadis</surname><given-names>M</given-names></name>, <name><surname>Minevich</surname><given-names>G</given-names></name>, <name><surname>Winchester</surname><given-names>R</given-names></name>, <name><surname>Shalekoff</surname><given-names>S</given-names></name>, <name><surname>Gray</surname><given-names>GE</given-names></name>, <etal>et al</etal><article-title>Natural killer cell responses to HIV-1 peptides are associated with more activating KIR genes and HLA-C genes of the C1 allotype</article-title>. <source>J Acquir Immune Defic Syndr</source>. <year>2011</year>;<volume>57</volume>: <fpage>181</fpage>–<lpage>189</lpage>. <pub-id pub-id-type="doi">10.1097/QAI.0b013e3182174a76</pub-id>
<?supplied-pmid 21407082?><pub-id pub-id-type="pmid">21407082</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0151364.ref015">
                <label>15</label>
                <mixed-citation publication-type="journal"><name><surname>Li</surname><given-names>H</given-names></name>, <name><surname>Peng</surname><given-names>SL</given-names></name>, <name><surname>Cui</surname><given-names>Y</given-names></name>, <name><surname>Fu</surname><given-names>QX</given-names></name>, <name><surname>Zhou</surname><given-names>Y</given-names></name>, <name><surname>Wang</surname><given-names>QL</given-names></name>, <etal>et al</etal><article-title>Kinetics of interaction of HLA-B2705 with natural killer cell immunoglobulin-like receptor 3DS1</article-title>. <source>Protein Pept Lett</source>. <year>2010</year>;<volume>17</volume>: <fpage>547</fpage>–<lpage>554</lpage>. <?supplied-pmid 19995342?><pub-id pub-id-type="pmid">19995342</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0151364.ref016">
                <label>16</label>
                <mixed-citation publication-type="journal"><name><surname>Boulet</surname><given-names>S</given-names></name>, <name><surname>Kleyman</surname><given-names>M</given-names></name>, <name><surname>Kim</surname><given-names>JY</given-names></name>, <name><surname>Kamya</surname><given-names>P</given-names></name>, <name><surname>Sharafi</surname><given-names>S</given-names></name>, <name><surname>Simic</surname><given-names>N</given-names></name>, <etal>et al</etal><article-title>A combined genotype of KIR3DL1 high expressing alleles and HLA-B*57 is associated with a reduced risk of HIV infection</article-title>. <source>AIDS</source>. <year>2008</year>;<volume>22</volume>: <fpage>1487</fpage>–<lpage>1491</lpage>. <pub-id pub-id-type="doi">10.1097/QAD.0b013e3282ffde7e</pub-id>
<?supplied-pmid 18614872?><pub-id pub-id-type="pmid">18614872</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0151364.ref017">
                <label>17</label>
                <mixed-citation publication-type="journal"><name><surname>Gaudieri</surname><given-names>S</given-names></name>, <name><surname>DeSantis</surname><given-names>D</given-names></name>, <name><surname>McKinnon</surname><given-names>E</given-names></name>, <name><surname>Moore</surname><given-names>C</given-names></name>, <name><surname>Nolan</surname><given-names>D</given-names></name>, <name><surname>Witt</surname><given-names>CS</given-names></name>, <etal>et al</etal><article-title>Killer immunoglobulin-like receptors and HLA act both independently and synergistically to modify HIV disease progression</article-title>. <source>Genes Immun</source>. <year>2005</year>;<volume>6</volume>: <fpage>683</fpage>–<lpage>690</lpage>. <?supplied-pmid 16121209?><pub-id pub-id-type="pmid">16121209</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0151364.ref018">
                <label>18</label>
                <mixed-citation publication-type="journal"><name><surname>Englund</surname><given-names>JA</given-names></name>, <name><surname>Baker</surname><given-names>CJ</given-names></name>, <name><surname>Raskino</surname><given-names>C</given-names></name>, <name><surname>McKinney</surname><given-names>RE</given-names></name>, <name><surname>Petrie</surname><given-names>B</given-names></name>, <name><surname>Fowler</surname><given-names>MG</given-names></name>, <etal>et al</etal><article-title>Zidovudine, didanosine, or both as the initial treatment for symptomatic HIV-infected children. AIDS Clinical Trials Group (ACTG) Study 152 Team</article-title>. <source>N Engl J Med</source>. <year>1997</year>;<volume>336</volume>: <fpage>1704</fpage>–<lpage>1712</lpage>. <?supplied-pmid 9182213?><pub-id pub-id-type="pmid">9182213</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0151364.ref019">
                <label>19</label>
                <mixed-citation publication-type="journal"><name><surname>McKinney</surname><given-names>RE</given-names><suffix>Jr</suffix></name>, <name><surname>Johnson</surname><given-names>GM</given-names></name>, <name><surname>Stanley</surname><given-names>K</given-names></name>, <name><surname>Yong</surname><given-names>FH</given-names></name>, <name><surname>Keller</surname><given-names>A</given-names></name>, <name><surname>O'Donnell</surname><given-names>KJ</given-names></name>, <etal>et al</etal><article-title>A randomized study of combined zidovudine-lamivudine versus didanosine monotherapy in children with symptomatic therapy-naive HIV-1 infection. The Pediatric AIDS Clinical Trials Group Protocol 300 Study Team</article-title>. <source>J Pediatr</source>. <year>1998</year>;<volume>133</volume>: <fpage>500</fpage>–<lpage>508</lpage>. <?supplied-pmid 9787687?><pub-id pub-id-type="pmid">9787687</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0151364.ref020">
                <label>20</label>
                <mixed-citation publication-type="journal"><name><surname>Raskino</surname><given-names>C</given-names></name>, <name><surname>Pearson</surname><given-names>DA</given-names></name>, <name><surname>Baker</surname><given-names>CJ</given-names></name>, <name><surname>Lifschitz</surname><given-names>MH</given-names></name>, <name><surname>O'Donnell</surname><given-names>K</given-names></name>, <name><surname>Mintz</surname><given-names>M</given-names></name>, <etal>et al</etal><article-title>Neurological, neurocognitive and brain growth outcomes in HIV-infected children receiving different nucleoside antiretroviral regimens</article-title>. <source>Pediatrics</source>. <year>1999</year>;<volume>104</volume>: <fpage>e32</fpage><?supplied-pmid 10469815?><pub-id pub-id-type="pmid">10469815</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0151364.ref021">
                <label>21</label>
                <mixed-citation publication-type="book"><name><surname>Bayley</surname><given-names>N</given-names></name>. <chapter-title>Bayley Scales of Infant Development: Birth to Two Years</chapter-title><publisher-loc>San Antonio, TX</publisher-loc>: <publisher-name>Psychological Corporation</publisher-name>; <year>1969</year>.</mixed-citation>
              </ref>
              <ref id="pone.0151364.ref022">
                <label>22</label>
                <mixed-citation publication-type="book"><name><surname>Wechsler</surname><given-names>D.</given-names></name><chapter-title>Wechsler Preschool and Primary Scales of Intelligence-Revised</chapter-title><publisher-loc>San Antonio, TX</publisher-loc>: <publisher-name>Psychological Corporation</publisher-name>; <year>1989</year>.</mixed-citation>
              </ref>
              <ref id="pone.0151364.ref023">
                <label>23</label>
                <mixed-citation publication-type="book"><name><surname>Wechsler</surname><given-names>D</given-names></name>. <chapter-title>Manual for the Wechsler Intelligence Scale for Children: Revised</chapter-title><publisher-loc>San Antonio, TX</publisher-loc>: <publisher-name>Psychological Corporation</publisher-name>; <year>1974</year></mixed-citation>
              </ref>
              <ref id="pone.0151364.ref024">
                <label>24</label>
                <mixed-citation publication-type="book"><name><surname>Wechsler</surname><given-names>D</given-names></name>. <chapter-title>Manual for the Wechsler Adult Intelligence Scale: Revised</chapter-title><publisher-loc>San Antonio, TX</publisher-loc>: <publisher-name>Psychological Corporation</publisher-name>; <year>1981</year></mixed-citation>
              </ref>
              <ref id="pone.0151364.ref025">
                <label>25</label>
                <mixed-citation publication-type="book"><name><surname>McCarthy</surname><given-names>DA</given-names></name>. <chapter-title>Manual for the McCarthy Scales of Children's Abilities</chapter-title><publisher-loc>San Antonio, TX</publisher-loc>: <publisher-name>Psychological Corporation</publisher-name>; <year>1972</year>.</mixed-citation>
              </ref>
              <ref id="pone.0151364.ref026">
                <label>26</label>
                <mixed-citation publication-type="journal"><name><surname>Singh</surname><given-names>KK</given-names></name>, <name><surname>Spector</surname><given-names>SA</given-names></name>. <article-title>Fidelity of whole-genome amplification of blood spot DNA for HLA typing and SNP analyses</article-title>. <source>Clin Genet</source>. <year>2007</year>;<volume>72</volume>: <fpage>156</fpage>–<lpage>159</lpage>. <?supplied-pmid 17661821?><pub-id pub-id-type="pmid">17661821</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0151364.ref027">
                <label>27</label>
                <mixed-citation publication-type="journal"><name><surname>De Re</surname><given-names>V</given-names></name>, <name><surname>Caggiari</surname><given-names>L</given-names></name>, <name><surname>De Zorzi</surname><given-names>M</given-names></name>, <name><surname>Repetto</surname><given-names>O</given-names></name>, <name><surname>Zignego</surname><given-names>AL</given-names></name>, <name><surname>Izzo</surname><given-names>F</given-names></name>, <etal>et al</etal><article-title>Genetic diversity of the KIR/HLA system and susceptibility to hepatitis C virus-related diseases</article-title>. <source>PLoS One</source>. <year>2015</year>;<volume>10</volume>: <fpage>e0117420</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0117420</pub-id><?supplied-pmid 25700262?><pub-id pub-id-type="pmid">25700262</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0151364.ref028">
                <label>28</label>
                <mixed-citation publication-type="journal"><name><surname>Ponte</surname><given-names>M</given-names></name>, <name><surname>Cantoni</surname><given-names>C</given-names></name>, <name><surname>Biassoni</surname><given-names>R</given-names></name>, <name><surname>Tradori-Cappai</surname><given-names>A</given-names></name>, <name><surname>Bentivoglio</surname><given-names>G</given-names></name>, <name><surname>Vitale</surname><given-names>C</given-names></name>, <etal>et al</etal><article-title>Inhibitory receptors sensing HLA-G1 molecules in pregnancy: decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptor</article-title>. <source>Proc Natl Acad Sci USA</source>. <year>1999</year>;<volume>96</volume>: <fpage>5674</fpage>–<lpage>5679</lpage>. <?supplied-pmid 10318943?><pub-id pub-id-type="pmid">10318943</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0151364.ref029">
                <label>29</label>
                <mixed-citation publication-type="journal"><name><surname>Rajagopalan</surname><given-names>S</given-names></name>, <name><surname>Fu</surname><given-names>J</given-names></name>, <name><surname>Long</surname><given-names>EO</given-names></name>. <article-title>Cutting edge: induction of IFN-g production but not cytotoxicity by the killer cell Ig-like receptor KIR2DL4 (CD158d) in resting NK cells</article-title>. <source>J Immunol</source>. <year>2001</year>;<volume>167</volume>: <fpage>1877</fpage>–<lpage>1881</lpage>. <?supplied-pmid 11489965?><pub-id pub-id-type="pmid">11489965</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0151364.ref030">
                <label>30</label>
                <mixed-citation publication-type="journal"><name><surname>Faure</surname><given-names>M</given-names></name>, <name><surname>Long</surname><given-names>EO</given-names></name>. <article-title>KIR2DL4 (CD158d), an NK cell-activating receptor with inhibitory potential</article-title>. <source>J Immunol</source>. <year>2002</year>;<volume>168</volume>: <fpage>6208</fpage>–<lpage>6214</lpage>. <?supplied-pmid 12055234?><pub-id pub-id-type="pmid">12055234</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0151364.ref031">
                <label>31</label>
                <mixed-citation publication-type="journal"><name><surname>Singh</surname><given-names>KK</given-names></name>, <name><surname>Gray</surname><given-names>PK</given-names></name>, <name><surname>Wang</surname><given-names>Y</given-names></name>, <name><surname>Fenton</surname><given-names>T</given-names></name>, <name><surname>Trout</surname><given-names>RN</given-names></name>, <name><surname>Spector</surname><given-names>SA</given-names></name>. <article-title>HLA alleles are associated with altered risk for disease progression and central nervous system impairment of HIV-infected children</article-title>. <source>J Acquir Immune Defic Syndr</source>. <year>2011</year>;<volume>57</volume>: <fpage>32</fpage>–<lpage>39</lpage>. <pub-id pub-id-type="doi">10.1097/QAI.0b013e3182119244</pub-id>
<?supplied-pmid 21283014?><pub-id pub-id-type="pmid">21283014</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0151364.ref032">
                <label>32</label>
                <mixed-citation publication-type="journal"><name><surname>Mandelboim</surname><given-names>O</given-names></name>, <name><surname>Reyburn</surname><given-names>HT</given-names></name>, <name><surname>Vale´s-Go´mez</surname><given-names>M</given-names></name>, <name><surname>Pazmany</surname><given-names>L</given-names></name>, <name><surname>Colonna</surname><given-names>M</given-names></name>, <name><surname>Borsellino</surname><given-names>G</given-names></name>, <etal>et al</etal><article-title>Protection from lysis by natural killer cells of group 1 and 2 specificity is mediated by residue 80 in human histocompatibility complex molecules</article-title>. <source>J Exp Med</source>. <year>1996</year>;<volume>184</volume>: <fpage>913</fpage>–<lpage>922</lpage>. <?supplied-pmid 9064351?><pub-id pub-id-type="pmid">9064351</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0151364.ref033">
                <label>33</label>
                <mixed-citation publication-type="journal"><name><surname>Boyington</surname><given-names>JC</given-names></name>, <name><surname>Sun</surname><given-names>PD</given-names></name>. <article-title>A structural perspective on MHC class I recognition by killer cell immunoglobulin-like receptors</article-title>. <source>Mol. Immunol</source>. <year>2002</year>;<volume>38</volume>: <fpage>1007</fpage>–<lpage>1021</lpage>. <?supplied-pmid 11955593?><pub-id pub-id-type="pmid">11955593</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0151364.ref034">
                <label>34</label>
                <mixed-citation publication-type="journal"><name><surname>Igarashi</surname><given-names>T</given-names></name>, <name><surname>Wynberg</surname><given-names>J</given-names></name>, <name><surname>Srinivasan</surname><given-names>R</given-names></name>, <name><surname>Becknell</surname><given-names>B</given-names></name>, <name><surname>McCoy</surname><given-names>JP</given-names><suffix>Jr</suffix></name>, <name><surname>Takahashi</surname><given-names>Y</given-names></name>, <etal>et al</etal><article-title>Enhanced cytotoxicity of allogeneic NK cells with killer immunoglobulin-like receptor ligand incompatibility against melanoma and renal cell carcinoma cells</article-title>. <source>Blood</source>. <year>2004</year>;<volume>104</volume>: <fpage>170</fpage>–<lpage>177</lpage>. <?supplied-pmid 15016654?><pub-id pub-id-type="pmid">15016654</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0151364.ref035">
                <label>35</label>
                <mixed-citation publication-type="journal"><name><surname>Parham</surname><given-names>P</given-names></name>. <article-title>MHC class I molecules and KIRs in human history, health and survival</article-title>. <source>Nat Rev Immunol</source>. <year>2005</year>;<volume>5</volume>: <fpage>201</fpage>–<lpage>214</lpage>. <?supplied-pmid 15719024?><pub-id pub-id-type="pmid">15719024</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0151364.ref036">
                <label>36</label>
                <mixed-citation publication-type="journal"><name><surname>Pan</surname><given-names>W</given-names></name>. <article-title>On the Robust Variance Estimator in Generalized Estimating Equations</article-title>. <source>Biometrika</source>. <year>2001</year>;<volume>88</volume>: <fpage>901</fpage>–<lpage>906</lpage>.</mixed-citation>
              </ref>
              <ref id="pone.0151364.ref037">
                <label>37</label>
                <mixed-citation publication-type="journal"><name><surname>Benjamini</surname><given-names>Y</given-names></name>, <name><surname>Hochberg</surname><given-names>Y</given-names></name>. <article-title>"Controlling the false discovery rate: a practical and powerful approach to multiple testing"</article-title>. <source>Journal of the Royal Statistical Society, Series B</source>. <year>1995</year>:<volume>57</volume>: <fpage>289</fpage>–<lpage>300</lpage>.</mixed-citation>
              </ref>
              <ref id="pone.0151364.ref038">
                <label>38</label>
                <mixed-citation publication-type="journal"><name><surname>Biron</surname><given-names>CA</given-names></name>, <name><surname>Nguyen</surname><given-names>KB</given-names></name>, <name><surname>Pien</surname><given-names>GC</given-names></name>, <name><surname>Cousens</surname><given-names>LP</given-names></name>, <name><surname>Salazar-Mather</surname><given-names>TP</given-names></name>. <article-title>Natural killer cells in antiviral defense: function and regulation by innate cytokines</article-title>. <source>Annu Rev Immunol</source>. <year>1999</year>;<volume>17</volume>: <fpage>189</fpage>–<lpage>220</lpage>. <?supplied-pmid 10358757?><pub-id pub-id-type="pmid">10358757</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0151364.ref039">
                <label>39</label>
                <mixed-citation publication-type="journal"><name><surname>De Maria</surname><given-names>A</given-names></name>, <name><surname>Mavilio</surname><given-names>D</given-names></name>, <name><surname>Costa</surname><given-names>P</given-names></name>, <name><surname>Dignetti</surname><given-names>P</given-names></name>, <name><surname>Fogli</surname><given-names>M</given-names></name>, <name><surname>Mingari</surname><given-names>MC</given-names></name>. <article-title>Multiple HLA-class I-specific inhibitory NK receptor expression and IL-4/IL-5 production by CD8+ T-cell clones in HIV-1 infection</article-title>. <source>Immunol Lett</source>. <year>2000</year>;<volume>72</volume>: <fpage>179</fpage>–<lpage>182</lpage>. <?supplied-pmid 10880839?><pub-id pub-id-type="pmid">10880839</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0151364.ref040">
                <label>40</label>
                <mixed-citation publication-type="journal"><name><surname>Merino</surname><given-names>AM</given-names></name>, <name><surname>Dugast A-</surname><given-names>S</given-names></name>, <name><surname>Wilson</surname><given-names>CM</given-names></name>, <name><surname>Goepfert</surname><given-names>PA</given-names></name>, <name><surname>Galit</surname><given-names>Alter</given-names></name>, <name><surname>Richard</surname><given-names>A</given-names></name>, <etal>et al</etal><article-title>KIR2DS4 Promotes HIV-1 Pathogenesis: New Evidence from Analyses of Immunogenetic Data and Natural Killer Cell Function</article-title>. <source>PLoS One</source>. <year>2014</year>;<volume>9</volume>: <fpage>e99353</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0099353</pub-id><?supplied-pmid 24901871?><pub-id pub-id-type="pmid">24901871</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0151364.ref041">
                <label>41</label>
                <mixed-citation publication-type="journal"><name><surname>Shieh</surname><given-names>TM</given-names></name>, <name><surname>Carter</surname><given-names>DL</given-names></name>, <name><surname>Blosser</surname><given-names>RL</given-names></name>, <name><surname>Mankowski</surname><given-names>JL</given-names></name>, <name><surname>Zink</surname><given-names>MC</given-names></name>, <name><surname>Clements</surname><given-names>JE</given-names></name>. <article-title>Functional analyses of natural killer cells in macaques infected with neurovirulent simian immunodeficiency virus</article-title>. <source>J Neurovirol</source>. <year>2001</year>;<volume>7</volume>: <fpage>11</fpage>–<lpage>24</lpage>. <?supplied-pmid 11519478?><pub-id pub-id-type="pmid">11519478</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0151364.ref042">
                <label>42</label>
                <mixed-citation publication-type="journal"><name><surname>Alter</surname><given-names>G</given-names></name>, <name><surname>Martin</surname><given-names>MP</given-names></name>, <name><surname>Teigen</surname><given-names>N</given-names></name>, <name><surname>Carr</surname><given-names>WH</given-names></name>, <name><surname>Suscovich</surname><given-names>TJ</given-names></name>, <name><surname>Schneidewind</surname><given-names>A</given-names></name>, <etal>et al</etal><article-title>Differential natural killer cell mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes</article-title>. <source>J Exp Med</source>. <year>2007</year>;<volume>204</volume>: <fpage>3027</fpage>–<lpage>3036</lpage>
<?supplied-pmid 18025129?><pub-id pub-id-type="pmid">18025129</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0151364.ref043">
                <label>43</label>
                <mixed-citation publication-type="journal"><name><surname>Lanier</surname><given-names>LL</given-names></name>. <article-title>NK cell receptors</article-title>. <source>Annu Rev Immunol</source>. <year>1998</year>;<volume>16</volume>: <fpage>359</fpage>–<lpage>393</lpage>. <?supplied-pmid 9597134?><pub-id pub-id-type="pmid">9597134</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0151364.ref044">
                <label>44</label>
                <mixed-citation publication-type="journal"><name><surname>Raulet</surname><given-names>DH</given-names></name>, <name><surname>Held</surname><given-names>W</given-names></name>. <article-title>Natural killer cell receptors: the offs and ons of NK cell recognition</article-title>. <source>Cell</source>. <year>1995</year>;<volume>82</volume>: <fpage>697</fpage>–<lpage>700</lpage>. <?supplied-pmid 7671299?><pub-id pub-id-type="pmid">7671299</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0151364.ref045">
                <label>45</label>
                <mixed-citation publication-type="journal"><name><surname>Hong</surname><given-names>HA</given-names></name>, <name><surname>Paximadis</surname><given-names>M</given-names></name>, <name><surname>Gray</surname><given-names>GE</given-names></name>, <name><surname>Kuhn</surname><given-names>L</given-names></name>, <name><surname>Tiemessen</surname><given-names>CT</given-names></name>. <article-title>KIR2DS4 allelic variants: Differential effects on in utero and intrapartum HIV-1 mother-to-child transmission</article-title>. <source>Clin Immunol</source>. <year>2013</year>;<volume>149</volume>: <fpage>498</fpage>–<lpage>508</lpage>. <pub-id pub-id-type="doi">10.1016/j.clim.2013.09.005</pub-id>
<?supplied-pmid 24239756?><pub-id pub-id-type="pmid">24239756</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0151364.ref046">
                <label>46</label>
                <mixed-citation publication-type="journal"><name><surname>Winchester</surname><given-names>R</given-names></name>, <name><surname>Pitt</surname><given-names>J</given-names></name>, <name><surname>Charurat</surname><given-names>M</given-names></name>, <name><surname>Magder</surname><given-names>LS</given-names></name>, <name><surname>Göring</surname><given-names>HH</given-names></name>, <name><surname>Landay</surname><given-names>A</given-names></name>, <etal>et al</etal><article-title>Mother-to-child transmission of HIV-1: strong association with certain maternal HLA-B alleles independent of viral load implicates innate immune mechanisms</article-title>. <source>J Acquir Immune Defic Syndr</source>. <year>2004</year>;<volume>36</volume>: <fpage>659</fpage>–<lpage>670</lpage>. <?supplied-pmid 15167284?><pub-id pub-id-type="pmid">15167284</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0151364.ref047">
                <label>47</label>
                <mixed-citation publication-type="journal"><name><surname>Ljunggren</surname><given-names>HG</given-names></name>, <name><surname>Karre</surname><given-names>K</given-names></name>. <article-title>In search of the “missing self”: MHC molecules and NK cell recognition</article-title>. <source>Immunol Today</source>. <year>1990</year>;<volume>11</volume>: <fpage>237</fpage>–<lpage>244</lpage>. <?supplied-pmid 2201309?><pub-id pub-id-type="pmid">2201309</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0151364.ref048">
                <label>48</label>
                <mixed-citation publication-type="other">Körner C, Simoneau CR, Granoff ME, Corleis B, Scully EP, Kwon DS, et al. Blockade of KIR2DL1/3 Significantly Improves the Anti-HIV-1 Activity of KIR+ NK Cells. Presented at CROI 2016, Feb 22–25; Boston, Massachusetts.</mixed-citation>
              </ref>
              <ref id="pone.0151364.ref049">
                <label>49</label>
                <mixed-citation publication-type="journal"><name><surname>Mori</surname><given-names>M</given-names></name>, <name><surname>Wichukchinda</surname><given-names>N</given-names></name>, <name><surname>Miyahara</surname><given-names>R</given-names></name>, <name><surname>Rojanawiwat</surname><given-names>A</given-names></name>, <name><surname>Pathipvanich</surname><given-names>P</given-names></name>, <name><surname>Tsuchiya</surname><given-names>N</given-names></name>, <name><surname>Miura</surname><given-names>T</given-names></name>, <etal>et al</etal><article-title>The effect of KIR2D-HLA-C receptor-ligand interactions on clinical outcome in a HIV-1 CRF01_AE-infected Thai population</article-title>. <source>AIDS</source>. <year>2015</year>;<volume>29</volume>: <fpage>1607</fpage>–<lpage>1615</lpage>. <pub-id pub-id-type="doi">10.1097/QAD.0000000000000747</pub-id>
<?supplied-pmid 26372271?><pub-id pub-id-type="pmid">26372271</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0151364.ref050">
                <label>50</label>
                <mixed-citation publication-type="journal"><name><surname>Olvera</surname><given-names>A</given-names></name>, <name><surname>Pérez-Álvarez</surname><given-names>S</given-names></name>, <name><surname>Ibarrondo</surname><given-names>J</given-names></name>, <name><surname>Ganoza</surname><given-names>C</given-names></name>, <name><surname>Lama</surname><given-names>JR</given-names></name>, <name><surname>Lucchetti</surname><given-names>A</given-names></name>, <etal>et al</etal><article-title>The HLA-C*04: 01/KIR2DS4 gene combination and human leukocyte antigen alleles with high population frequency drive rate of HIV disease progression</article-title>. <source>AIDS</source>. <year>2015</year>;<volume>29</volume>: <fpage>507</fpage>–<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1097/QAD.0000000000000574</pub-id>
<?supplied-pmid 25715101?><pub-id pub-id-type="pmid">25715101</pub-id></mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
